{"id":5131,"date":"2026-06-26T21:57:17","date_gmt":"2026-06-26T21:57:17","guid":{"rendered":"https:\/\/oshot.info\/members\/?p=5131"},"modified":"2026-06-26T21:57:17","modified_gmt":"2026-06-26T21:57:17","slug":"jcpm2026-06-16-peyronies-c-section-prp-showers-vs-growers","status":"publish","type":"post","link":"https:\/\/oshot.info\/members\/jcpm2026-06-16-peyronies-c-section-prp-showers-vs-growers\/","title":{"rendered":"JCPM2026.06.16 | Peyronie&#8217;s | C-Section &#038; PRP | &#8220;Showers vs. Growers&#8221;"},"content":{"rendered":"<div title=\"header\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.46in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"font-size: xx-large; color: #252525; background-color: transparent; letter-spacing: 0.3pt;\">JCPM2026.06.16<\/span><\/p>\n<\/div>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><span style=\"color: #000000;\">The following is an edited transcript of the <\/span><span style=\"color: #000000;\"><i>Journal Club with Pearls &amp; Marketing<\/i><\/span><span style=\"color: #000000;\"> (JCPM) of June 16, 2026, with Charles Runels, MD. <\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/wp-content\/uploads\/2026\/06\/JCPM2026.06.16final-edit.pdf\" target=\"_blank\" rel=\"noopener\">&gt;-&gt; The PDF of this live journal club can be seen here &lt;-&lt;<\/a><\/u><\/span><\/p>\n<div style=\"padding: 56.25% 0 0 0; position: relative;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%;\" title=\"JCPM2026.06.16\" src=\"https:\/\/player.vimeo.com\/video\/1204956243?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479\" frameborder=\"0\"><\/iframe><\/div>\n<p><script src=\"https:\/\/player.vimeo.com\/api\/player.js\"><\/script><\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Topics Covered<\/h1>\n<ul>\n<li value=\"1\">\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Showers vs. Growers: Penile Proportion, the Tunica Albuginea, and the Penis Pump<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Draining a Baker Cyst with PRP \u2014 and What It Means for Bartholin's Cysts<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">PRP in Hyperlipidemia: What to Do About Milky Plasma<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">The Counter-Argument Paper: PRP for Erectile Dysfunction in Urology<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">PRP for C-Section Healing (and an O-Shot\u00ae Add-On for Delivery)<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Comparing the Botulinum Toxins: Xeomin, Dysport, Botox, and Daxxify<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Using AI as a Tool, Not a Substitute for You<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Penile Fracture Repair After Xiaflex for Peyronie's<\/span><\/strong><\/em><\/p>\n<\/li>\n<li>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.04in; direction: ltr; background: transparent;\" align=\"left\"><em><strong><span style=\"font-size: medium; color: #800080;\">Dyspareunia After Pelvic Radiotherapy for Rectal Cancer<\/span><\/strong><\/em><\/p>\n<\/li>\n<\/ul>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; margin-top: 0.06in;\" align=\"left\"><a href=\"https:\/\/runels.com\/\"> <img loading=\"lazy\" decoding=\"async\" style=\"max-width: 100%; height: auto;\" src=\"data:image\/jpeg;base64,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\" width=\"169\" height=\"134\" name=\"Picture 2\" align=\"left\" border=\"0\" hspace=\"12\" \/> <\/a><\/p>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #f07f09;\"><span style=\"font-size: small;\"><b>Charles Runels, MD<br \/>\nAuthor, researcher, and inventor of the Vampire Facelift\u00ae, Orchid Shot\u00ae (O-Shot\u00ae), Priapus Shot\u00ae (P-Shot\u00ae), Priapus Toxin\u00ae, Vampire Breast Lift\u00ae, and Vampire Wing Lift\u00ae, &amp; Clitoxin\u00ae procedures.<\/b><\/span><\/span><\/p>\n<p style=\"line-height: 100%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.21in; direction: ltr; background: transparent; letter-spacing: 0.3pt; border-top: none; border-bottom: 1pt solid #f07f09; border-left: none; border-right: none; padding: 0 0 0.06in 0;\" align=\"left\"><span style=\"color: #252525;\"><span style=\"font-size: xx-large;\">Transcript<\/span><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Welcome to our journal club. Don't let that long list scare you. There were quite a number of papers this week that I thought were wonderful, but I'll still just touch on them quickly and tell you which ones I think really relate to which procedure and why. Then, if you want to dive deeper, you'll know where to go. And even if you don't dive deeper, you'll find some things today that I think you'll consider very helpful.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Showers vs. Growers: Penile Proportion, the Tunica Albuginea, and the Penis Pump<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This first one I thought was wonderful, because it\u2019s about guys my dad used to call the \u201cbank walkers.\u201d [When you\u2019re in rural Alabama and swimming in the creek,] The bank walkers are the ones who are proud of what they have; then you have the ones who are embarrassed, so they wade around in the cold water so nobody can see.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Well, are there actually people whose erect penis is out of proportion to their non-erect penis?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">What they found was that there's actually some truth to it.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote1sym\" name=\"sdfootnote1anc\"><sup>1<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This was 420 men, and their conclusion was that the growth patterns were associated with tunica albuginea compression, and that reduced compression was associated with a venous leak. They also showed that thickness varied: people who were \u201cshowers\u201d had thinner tunica albuginea, allowing it to grow more. And of course, a venous leak is going to make it grow less proportionally.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">That was interesting. I'd always thought that if your flaccid penis isn't as big, your erect penis probably isn't going to be as big either, but not so. I think this also makes the case for why you might want to use a penis pump (we've talked about this before). When you're using that pump, you're basically stretching out the tissue like you would a hard-to-blow-up party balloon, which makes sense because it effectively thins the tissue.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So this is important. I don't know if I've ever shown you guys this, but if you go to <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/priapusshot.com\/pump\">priapusshot.com\/pump<\/a><\/u><\/span>, I built something you can show your patients. There's a 30-minute lecture right there about why the pump might be helpful, and I go into the physics of balloons, how anaerobic conditions trigger growth, and why it might work.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">There's the outline right there: safety, how to use it. So if you put a patient on a penis pump, you can send them to this page, and I'll explain to them why it might be helpful.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You could do your own version of that, and that's good. You're in the group; I don't care, copy everything I do and put it on your website.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">B<a href=\"https:\/\/botoxclass.com\/\"> <img loading=\"lazy\" decoding=\"async\" style=\"max-width: 100%; height: auto;\" src=\"data:image\/jpeg;base64,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\" width=\"233\" height=\"332\" name=\"Image2\" align=\"left\" border=\"0\" hspace=\"12\" \/> <\/a> ut until then, you can send them there or tell them about it after you do a <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/priapusshot.com\/\">P-Shot\u00ae<\/a><\/u><\/span> and put them on a penis pump. Remember, the British Journal of Urology showed, now over 10 years ago, that in men with Peyronie's disease, just a pump twice a day for 10 minutes was enough to improve symptoms that 51 percent canceled their surgery for Peyronie's disease.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote2sym\" name=\"sdfootnote2anc\"><sup>2<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/jcpm2026-06-02\/\">And if you were here last week<\/a><\/u><\/span>, you saw the paper we reviewed, where surgical treatment of Peyronie's gave you a 22 percent chance of developing erectile dysfunction if you had normal function when you had the surgery.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote3sym\" name=\"sdfootnote3anc\"><sup>3<\/sup><\/a><\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Draining a Baker Cyst &amp; Adding PRP \u2014 and What It Means for Bartholin's Cysts<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I put this one in here because, if you've done family practice or worked in the ER or orthopedics at all, you know a Baker cyst can rupture and be an acute, painful knee. They showed here that if you drain a Baker cyst versus drain it and instill PRP, you get more rapid healing with less pain.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote4sym\" name=\"sdfootnote4anc\"><sup>4<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Most of us are not draining Baker cysts. It used to be something I might do in the emergency room, but I was more likely to see them after an acute rupture. I've carefully watched the orthopedic literature, because they're at least 10, maybe 20 years ahead of what we're doing in aesthetics, urogynecology, and erectile dysfunction. So that's worth knowing about, because of the ways it may apply to what we do.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We don't have Baker cysts, but we have cysts, right?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">A Bartholin's gland cyst, for example: draining a Bartholin's gland cyst and then instilling PRP might create a more rapid and less painful healing for those of you who treat that occasionally.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Something else I used to treat in the ER.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">PRP in Hyperlipidemia: What to Do About Milky Plasma<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This one brings up something that's been asked, and the first time I was asked it, I didn't know the answer, so I had to go read. So it's not just what you tell me, it's what you ask me that prompts me to go read and bring it back to you.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Sometimes you'll draw the blood and spin your whole blood, and you'll wind up with platelet-rich plasma that looks milky, because the patient has a severe hyperlipidemia. As they say in the discussion, there's not much data, but in vitro studies suggest it may reduce effectiveness.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote5sym\" name=\"sdfootnote5anc\"><sup>5<\/sup><\/a> I've treated a number of people over the past decade-plus, maybe a dozen, who had that scenario, and they did fine, they did well. But I haven't done the study to see how efficacy of the PRP shot with hyperlipidemia compares with efficacy without it. The common-sense suggestion is that maybe they should just not eat, or at least not eat anything fatty, for 8 to 12 hours beforehand.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So that's a scenario to plan for. Hopefully you get it on history before they ever show up, but that may not happen.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So if you draw the blood, spin it, and see that milky plasma, their suggestion is that you could bring them back and tell them not to eat any fatty foods, or just to fast, for 8 to 12 hours. Well, that's simple, as good ideas usually are. I didn't think of that the last time we discussed this, but it's worth thinking about. So there's another answer to that dilemma.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">The Counter-Argument Paper: PRP for Erectile Dysfunction in Urology<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I put this one here<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote6sym\" name=\"sdfootnote6anc\"><sup>6<\/sup><\/a> because it's counter to what we're doing, and it's so interesting. For example, two meta-analyses show that PRP in the corpus cavernosum is effective.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote7sym\" name=\"sdfootnote7anc\"><sup>7<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">There was one study that showed it was not effective in a placebo-controlled, double-blind trial \u2014 one; but in that study, they used half the amount of PRP we use, they did not activate the PRP with CaCl (we do), and saline was the placebo, which is not a placebo; it's another treatment.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote8sym\" name=\"sdfootnote8anc\"><sup>8<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So there was another variable that just seems to get overlooked when people talk about that paper.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">If I'm on Viagra and you allow me to stop it the same day you give me a P-Shot\u00ae, that's two variables. If you're part of a group, you know that what we do is have them stay on the medication, whatever they're doing, Trimix or a PDE5 inhibitor. Then, as things start to improve \u2014 which usually starts around the third week, not that day \u2014 they can start to taper off the medication, and that's just one variable: you added a P-Shot\u00ae to what they're normally doing.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/accma.memberlodge.org\/page-925782\">=&gt;Next Hands-On Workshops with Live Models&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">If you're going to do more than one variable, I think it should be positive things: let's start you on testosterone, start walking every day, do a P-Shot\u00ae, make sure you don't have hyperprolactinemia, and make sure your estradiol isn't too low.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Are you on blood pressure medication that needs to be swapped? Antidepressants that need to be swapped around?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">All those things you know to do to make things better. But to make something worse at the same time you're making it better is two variables, and that's what was done in the one that didn't work: there was no statistical difference between the \"placebo\" and the treatment arm. But at six months, the increase in score was only two in the placebo arm and five in the treatment arm. Both were statistically significant compared to baseline. Both treatment arms worked (improved IIEF-EF), and PRP worked better than placebo, even at a half dose and without activation.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Other double-blind, placebo-controlled studies, even though they were using saline, did work.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote9sym\" name=\"sdfootnote9anc\"><sup>9<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Now, look at this conclusion: I want to present counterarguments to what we're doing\u2014not hide them, but present them and discuss them. \"PRP remains an investigational therapy in urology. Its biological rationale is compelling.\" By the way, none of the studies show any significant downsides, no serious sequela. \"The current clinical evidence is insufficient to support broad routine use. Future progress depends on standardized PRP characterization, reporting, disease-specific sham-controlled trials, consistent outcome measures, and longer follow-up.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Here's the thing<i><b>: we have a protocol<\/b><\/i> \u2014 the standardized PRP characterization and reporting. We have protocols. And what does the rest of it actually mean?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">A sham-controlled trial doesn't show what it's supposed to when a placebo does almost as well, if it's not really a placebo. We have studies showing that even just needling triggers a regenerative process.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote10sym\" name=\"sdfootnote10anc\"><sup>10<\/sup><\/a> So even if you just stick a needle in soft tissue \u2014 saline through an IV compared to a drug is a placebo, but not when you're hydrodissecting tissue.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">The other thing is that the first-line therapies out there are not disease-reversing. PDE5 inhibitors and Trimix don't arrest or slow the pathophysiology if it's neurovascular.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">What we're doing is a targeting mechanism. So it doesn't negate what they've said, but it's another reason to do what we're doing.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote11sym\" name=\"sdfootnote11anc\"><sup>11<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Here's the main thing I'm trying to get to. If you're practicing ahead of a formal guideline endorsement, that's normal and legitimate. We do things off-label. In some studies, 40 percent of the drugs family practitioners prescribe are off-label.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote12sym\" name=\"sdfootnote12anc\"><sup>12<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So what you're doing in the clinic doesn't have to match the formal guideline endorsements. Once that happens, insurance is on the hook to pay us; while someone's paying us, we can charge what it's worth, and we can give it away to those who can't afford it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So the society bodies haven't endorsed it for routine use. That still does not mean we can't, as licensed doctors, offer it to an informed, consenting patient. We can. Those two things are not in conflict. To make sure it's done properly, we just need a consent form, and the more candid it is, the more defensible it is.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So we have a strong consent form \u2014 use it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We list just about everything that could ever go wrong. And even though the FDA has said in black and white that it does not regulate PRP \u2014 we don't have to guess at that, it's in black and white \u2014 we still say that the FDA hasn't endorsed it, just so people know that, and you can say that the controlled trials are still inconclusive.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote13sym\" name=\"sdfootnote13anc\"><sup>13<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">At the same time, we have <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/priapusshot.com\/members\/directory\">thousands of physicians literally in our group<\/a><\/u><\/span>, not counting the knock-offs of what we started. So, this isn't going away. It's just not to the point where Blue Cross is going to start paying for it. That's the way I'm looking at it, and I think that's a safe way to think about it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So let's go to the next one. I always want to show you what's counter to what we're doing, and that can be disheartening. On the one hand, you need good enemies to keep you smart. I wouldn't say enemies, but counter-thought makes you smarter, because it challenges you to read more, think more, and move science forward.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">PRP for C-Section Healing (and an O-Shot\u00ae Add-On for Delivery)<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/prp-training-runels\/\">We do a hands-on workshop<\/a><\/u><\/span> \u2014 it used to be every month, but now it's every other month, and I'm doing one next month. In the workshop we did last week, there were two gynecologists, amazing, brilliant ladies from Louisiana, and they're still delivering babies. They're working hard, 24\/7, like many of you \u2014 sleeping some, but often working, sleeping every second or third day, delivering children.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Here's a nice article on how PRP can help with healing after a C-section.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote14sym\" name=\"sdfootnote14anc\"><sup>14<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">It's a review article and meta-analysis because there have been many of these studies. I won't go into it any more than to say you've got strong reasons to ask your hospital to allow that in your labor-and-delivery room, or in the OR where you do your C-sections.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We had a physician pass through our workshop, I guess five or six years ago now, who went all-cash as an OB-GYN. He's still delivering children, but he decided to do it outside insurance\u2014offer it free to those he wanted to treat as charity, and charge what it's worth to those who could afford it, which meant they got more attention and a lot of other things. If you're doing a cash practice for obstetrics, this could be part of the \"more\" that you provide.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">If I were going to do that, I'd also offer a routine <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshot.info\/\">O-Shot\u00ae<\/a><\/u><\/span> around the urethra, and even augment it with PRP posteriorly and in some of the muscles, to help recovery from a vaginal delivery.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">That could be added to an insurance practice, too. Since insurance doesn't pay for it, you could have an insurance-paid delivery and then offer an add-on \u2014 treating the wound, the pelvic floor, the introitus, and a regular O-Shot\u00ae \u2014 all while the woman is anesthetized, for a possibly better outcome.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Comparing the Botulinum Toxins: Xeomin, Dysport, Botox, and Daxxify<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This is a review, and it is the best I've seen lately.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote15sym\" name=\"sdfootnote15anc\"><sup>15<\/sup><\/a> I'll give you the link to it. Without a doubt, it's the best recent comparison of the different FDA-approved, market-available botulinum toxins.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I get this question a lot: why choose Xeomin versus Dysport versus Botox? This is a really beautiful review of why one might work better than another, depending on the indication.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Apply for <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Online Training for Multiple PRP Procedures<\/i><\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">My sweet wife has come to the conclusion \u2014 we haven't done this study yet \u2014 that one of the botulinum toxins works better than the others for treating sexual dysfunction with botulinum toxin in women. Her observation has been that Daxxify works great cosmetically, but is not performing as well for sexual function, and she's got some reasons for that. It makes sense, and this paper supports that idea.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So we're mostly using Xeomin\u00ae or Botox\u00ae these days. You could use Dysport, but I think Daxxify, although it's a great choice for aesthetic use, might work less effectively for sexual function. It's anecdotal, but it makes sense why it might, and it has to do with autonomic tone.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I think I had to pay $30 or so for this article because it wasn't open source. <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/journals.lww.com\/10.1097\/SCS.0000000000013067\">Let me give you the link<\/a><\/u><\/span> if you want to go through it.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">But if you want the quick version: your best bang for the buck for cosmetic work is Daxxify or Xeomin, and for sexual dysfunction it's Xeomin or Dysport.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Botox probably works very well for all of it, but they get you on the price.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Using AI as a Tool, Not a Substitute for You<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">In this past hands-on workshop, I always do a marketing piece, and it evolves as the technology evolves and as our procedures evolve. Some of you know that I've built the websites and handle the marketing myself, and recently I've gone back to experimenting with paid advertising, though I really haven't done much of that at all.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">In other words, I understand the software, and I spend a lot of time and money on it trying to figure out what's best, and I'll give you some ideas.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This past workshop, I showed some of the tools I'm using now. I've bought more than a dozen different AIs \u2014 of course I have Claude and ChatGPT, but I also have Julius and a dozen others that I play around with.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I went through my top two or three and how I'm using them, and it was well received. So I think I'm going to do a separate meeting, maybe 30 minutes to an hour, just on that sometime in the future. Watch your email. It'll probably be tied to the <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/5notes.com\/\">5-Notes<\/a><\/u><\/span> marketing system most of you have. If you don't have that, call our group or our headquarters, or email us to let them know you want it, and they'll help you get signed in. I don't want to talk about it here because it's just for our members, and sometimes non-members hear these recordings.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I don't claim to be an expert on these large language model AI bots, but I'm spending quite a bit of time thinking about them, and I'll show you my favorite tools and how I'm using them as a physician.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Here's the thing to watch out for. I just read an article about the 4-Hour Workweek guy (Tim Ferris), who's made many millions online with his podcast, and he said that in the past year, his book sales have tanked. Why buy the book and read it when you can ask AI to tell you how to apply it?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So nonfiction books are tanking \u2014 and I don't mean 5 percent, I mean a 25 percent to 50 percent decrease in sales. Tim Ferriss is a smart guy. He has a very popular podcast and several nonfiction books that have sold well, but he says sales have been off by 25% to 50% in the past year.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Elon Musk read Tim Ferriss's 4-Hour Workweek \u2014 not to learn how to work four hours.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">He said nobody changes the world working even 40 hours a week. He works a lot more than that. But he took what he learned in the 4-Hour Workweek and applied it to build, <i><b>as a part-time job<\/b><\/i>, his SpaceX business, which has now made him a trillionaire, on 10 hours a week, because he had so many other things he was doing.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So what's the fix, and how does it relate to the people on this call?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">It's very simple: <i><b>your patients want to see you. <\/b><\/i><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">You can use the chat, or the large language models \u2014 which is why I brought this up \u2014 to help follow up with people in some way. But what people want is a real person. They want a real personality, and your patients want to know that you are in that language model.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">One of our smart physicians installed an app on his website that impersonates him. But it's able to pretend because he created the content that's on that website.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">One of the gurus I studied under said, \"You need at least 10 times as much stuff put into the large language model, into the AI \u2014 for every word you want it to send out, you need 10 words that you taught it.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And the other thing is that even when it talks about something \u2014 I've given you emails that were written for the research we're looking at, and some of it I wrote, and some of it was me writing along with the AI, but with every one of them I've asked you to please put yourself in it. That means your name and phone number, of course, but it also needs to be you adding your experience: the patient you saw, what happened, the fact that you've seen 10 people with this, the before-and-after picture you saw. When people just see a generic thing come through, and not a person in it, it's AI \u2014 and that's not what they're paying you for.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">They could just pull up their own ChatGPT instead of going to you. So that's part of what I want to show you in a whole separate meeting: how to use it as a tool, not as a substitute for you, so that your people will still show up and not feel like you're just a cardboard person.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Penile Fracture Repair After Xiaflex for Peyronie's<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I wanted to cover one on penile fracture repair. I'd been talking to one of the gurus in sexual medicine about my concern over penile fracture with Xiaflex and Peyronie's disease. The research is somewhere around 1.5 to 2 percent that you get a penile fracture, and he just scoffed at my concern and said, \"Well, it's not that big a deal. If we need to, we can fix it with an implant, and not everybody needs an implant.\"<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Well, this last paper, last week, showed that in men who have sex with men, the fracture rate is more like 11 percent.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote16sym\" name=\"sdfootnote16anc\"><sup>16<\/sup><\/a> The numbers participating in the study were small but statistically significant: 11 percent of those treated with Xiaflex for Peyronie's got a penile fracture.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So if that must be repaired, what's the scoop on it?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">This is an editorial on a 182-patient retrospective study, and the main point is that after surgical repair, erectile dysfunction was 16 percent, and penile curvature was 10 percent.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote17sym\" name=\"sdfootnote17anc\"><sup>17<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">That's what you're looking at post-op. So if you crack that thing \u2014 if you get Xiaflex and it cracks and you fracture it and you have to go for surgery \u2014 you're looking at somewhere pushing 15 to 20 percent, close to a one-in-five chance, that you're going to have ED. So you went from a crooked pencil to a limp noodle.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And then the next step, of course, is going to be a penile implant.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote18sym\" name=\"sdfootnote18anc\"><sup>18<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">So it's not a benign thing. If I had Peyronie's, the question I'd want to know is those numbers, so I get to decide.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">Do I really want my first choice to be Xiaflex, which carries somewhere between 2 and 11 percent chance of penile fracture, which then gives me a one-in-five chance of ED?<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And I'm also still concerned that I can't find another country outside the US \u2014 not Europe, Japan, or Canada \u2014 where it's still on formulary. Collagenase clostridium histolyticum, sold as XIAFLEX\u00ae in the U.S. and Xiapex\u00ae in Europe, was withdrawn or discontinued from normal commercial availability in Europe, Canada, Australia\/New Zealand, and parts of Asia\/Pacific by 2019\u20132020, <i>apparently<\/i> for \u201ccommercial\u201d rather than safety reasons. The strongest single-source statement is from Dupuytren Research Group, while Health Canada, Medsafe New Zealand, EMA, and Tanner Pharma provide country\/region-specific confirmation.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Dyspareunia After Pelvic Radiotherapy for Rectal Cancer<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">I just wanted to mention this one. It has to do with women who have pain with sex after being treated with pelvic radiotherapy.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote19sym\" name=\"sdfootnote19anc\"><sup>19<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">We see this both for rectal cancer and for breast cancer in women, but this one is specifically for rectal cancer. We've had people with dyspareunia come in to see our doctors, and I've had multiple anecdotal reports that our O-Shot\u00ae has helped them with their dryness and dyspareunia.<a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote20sym\" name=\"sdfootnote20anc\"><sup>20<\/sup><\/a><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">That's not what this paper is about; I bring it here just to remind you that this is a side effect, and that if a patient has been treated for rectal cancer with radiation, there's a very good chance their sex life is going to be impacted \u2014 and you have help for that. So that's worth talking about.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">All right, I sure hope that was helpful to you. Thank you for being on the call. Have a great week.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">And watch your email \u2014 I'll send one out for the webinar where we talk about the new AI chatbots. So long.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Apply for <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Online Training for Multiple PRP Procedures<\/i><\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/acrobat.adobe.com\/id\/urn:aaid:sc:US:bf4a1bbd-ce92-4d8f-a909-47a7d2395a0d\">=&gt;Benefits of the Cellular Medicine Association&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/accma.memberlodge.org\/page-925782\">=&gt;Next Hands-On Workshops with Live Models&lt;=<\/a><\/u><\/span><\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">References<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Ajeet Singh, Roshan, and Elaine Redmond. \u201cComment on: Long-Term Outcomes and Risk Factors for Erectile Dysfunction and Penile Curvature after Surgical Penile Fracture Repair.\u201d <i>International Journal of Impotence Research<\/i>, ahead of print, June 15, 2026. https:\/\/doi.org\/10.1038\/s41443-026-01297-6.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Akarsu, O\u011fuz, Ayhan A\u015fkin, Korhan Bar\u0131\u015f Bayram, Dilek Mert, and \u0130lker \u015eeng\u00fcl. \u201cUltrasound-Guided Aspiration of Baker\u2019s Cyst Combined With Intracystic Platelet-Rich Plasma Injection in Knee Osteoarthritis: A Randomized Controlled Trial.\u201d <i>American Journal of Physical Medicine &amp; Rehabilitation<\/i>, ahead of print, June 15, 2026. https:\/\/doi.org\/10.1097\/PHM.0000000000003065.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Anastasiadis, Eleni, Razna Ahmed, Abbas Khizar Khoja, and Tet Yap. \u201cErectile Dysfunction: Is Platelet-Rich Plasma the New Frontier for Treatment in Patients with Erectile Dysfunction? A Review of the Existing Evidence.\u201d <i>Frontiers in Reproductive Health<\/i> 4 (August 2022): 944765. https:\/\/doi.org\/10.3389\/frph.2022.944765.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Asghar, Aneela, Zahid Tahir, Aisha Ghias, Usma Iftikhar, and Tahir Jameel Ahmad. \u201cEfficacy and Safety of Intralesional Normal Saline in Atrophic Acne Scars.\u201d <i>Annals of King Edward Medical University<\/i> 25, no. 2 (2019): 2. https:\/\/doi.org\/10.21649\/akemu.v25i2.2867.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Bagherani, Nooshin, and Bruce R Smoller. \u201cIntroduction of a Novel Therapeutic Option for Atrophic Acne Scars: Saline Injection Therapy.\u201d <i>Global Dermatology<\/i> 2, no. 6 (2016). https:\/\/doi.org\/10.15761\/GOD.1000159.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Beitzel, Knut, Donald Allen, John Apostolakos, et al. \u201cUS Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine.\u201d <i>The Journal of Knee Surgery<\/i> 28, no. 1 (2015): 29\u201334. https:\/\/doi.org\/10.1055\/s-0034-1390030.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Bokey, E. L., J. P. Keating, and P. Zelas. \u201cHYDRODISSECTION: AN EASY WAY TO DISSECT ANATOMICAL PLANES AND COMPLEX ADHESIONS.\u201d <i>ANZ Journal of Surgery<\/i> 67, no. 9 (1997): 643\u201344. https:\/\/doi.org\/10.1111\/j.1445-2197.1997.tb04616.x.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Chaudry, Aysham, Alexandra DeVries, Wilhelmina Lam, Alec Lawson, and Mark S. Nestor. \u201cNeuromodulators for Facial Aesthetics: Key Clinical Postulates.\u201d <i>Journal of Craniofacial Surgery<\/i>, ahead of print, June 16, 2026. https:\/\/doi.org\/10.1097\/SCS.0000000000013067.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Chen, Anita H., Emanuel C. Trabuco, Saranya Chumsri, et al. \u201cPlatelet-Rich Plasma for Genitourinary Syndrome of Menopause in Breast Cancer Survivors.\u201d <i>Obstetrics &amp; Gynecology<\/i>, ahead of print, September 19, 2025. https:\/\/doi.org\/10.1097\/AOG.0000000000006081.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Chung. \u201cA Review of Current and Emerging Therapeutic Options for Erectile Dysfunction.\u201d <i>Medical Sciences<\/i> 7, no. 9 (2019): 91. https:\/\/doi.org\/10.3390\/medsci7090091.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Chung, Doo Yong, Ji-Kan Ryu, and Guo Nan Yin. \u201cRegenerative Therapies as a Potential Treatment of Erectile Dysfunction.\u201d <i>Investigative and Clinical Urology<\/i> 64, no. 4 (2023): 312\u201324. https:\/\/doi.org\/10.4111\/icu.20230104.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Chung, Eric. <i>Medical Sciences A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction<\/i>. 2019, 1\u201311.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Cocci, Andrea, Paolo Capogrosso, Suks Minhas, et al. \u201cPenile Prosthesis Implantation: A Systematic Review of Intraoperative and Postoperative Complications.\u201d <i>International Journal of Impotence Research<\/i>, ahead of print, June 13, 2025. https:\/\/doi.org\/10.1038\/s41443-025-01108-4.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Commissioner, Office of the. \u201cUnderstanding Unapproved Use of Approved Drugs \u2018Off Label.\u2019\u201d FDA, FDA, April 18, 2019. https:\/\/www.fda.gov\/patients\/learn-about-expanded-access-and-other-treatment-options\/understanding-unapproved-use-approved-drugs-label.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Du, Dan, and Yuan Liang. \u201cA Meta-Analysis and Systematic Review of the Clinical Efficacy and Safety of Platelet-Rich Plasma Combined with Hyaluronic Acid (PRP + HA) versus PRP Monotherapy for Knee Osteoarthritis (KOA).\u201d <i>Journal of Orthopaedic Surgery and Research<\/i> 20, no. 1 (2025): 57. https:\/\/doi.org\/10.1186\/s13018-024-05429-w.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Du, Shaokang, Shiwei Sun, Fuyu Guo, and Hongyao Liu. \u201cEfficacy of Platelet-Rich Plasma in the Treatment of Erectile Dysfunction: A Meta-Analysis of Controlled and Single-Arm Trials.\u201d <i>PLOS ONE<\/i> 19, no. 11 (2024): e0313074. https:\/\/doi.org\/10.1371\/journal.pone.0313074.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">El-Amawy, Heba Saed, and Sameh Magdy Sarsik. \u201cSaline in Dermatology: A Literature Review.\u201d <i>Journal of Cosmetic Dermatology<\/i> 20, no. 7 (2021): 2040\u201351. https:\/\/doi.org\/10.1111\/jocd.13813.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Francomano, Davide, Stefano Iuliano, Federico Deh\u00f2, et al. \u201cRegenerative Treatment with Platelet-Rich Plasma in Patients with Refractory Erectile Dysfunction: Short-Term Outcomes and Predictive Value of Mean Platelet Volume.\u201d <i>Minerva Endocrinology<\/i>, ahead of print, September 2023. https:\/\/doi.org\/10.23736\/S2724-6507.23.04060-5.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Garcia, MM, TM Fandel, G. Lin, et al. <i>Treatment of Erectile Dysfunction in the Obese Type 2 Diabetic ZDF Rat with Adipose Tissue-Derived Stem Cells<\/i>. 2010, 14.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Garc\u00eda-G\u00f3mez, Borja, Miguel Jarillo-Ochoa, Esther Garc\u00eda-Rojo, Guillermo Celada-Luis, Javier Romero-Otero, and Manuel Alonso-Isa. \u201cGrower or Shower: Is It Even a Thing? Penile Growth Patterns and Erectile Dysfunction Aetiology in Growers and Showers.\u201d <i>Andrology<\/i>, ahead of print, June 16, 2026. https:\/\/doi.org\/10.1111\/andr.70284.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Hames, A., and H. A. Wynne. \u201cUnlicensed and Off-Label Drug Use in Elderly People.\u201d <i>Age and Ageing<\/i> 30, no. 6 (2001): 530\u201331. https:\/\/doi.org\/10.1093\/ageing\/30.6.530-a.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Hinojosa-Gonzalez, David E., Gal Saffati, Daniela Orozco Rendon, et al. \u201cRegenerative Therapies for Erectile Dysfunction: A Systematic Review, Bayesian Network Meta-Analysis, and Meta-Regression.\u201d <i>The Journal of Sexual Medicine<\/i>, October 17, 2024, qdae131. https:\/\/doi.org\/10.1093\/jsxmed\/qdae131.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Hu, Shaohua, Zhenli Zhao, Zhisheng Wan, et al. \u201cThe Effect of Platelet-Rich Fibrin on the Biological Properties of Urothelial Cells.\u201d <i>Scientific Reports<\/i> 14, no. 1 (2024): 24527. https:\/\/doi.org\/10.1038\/s41598-024-75699-1.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Huang, Long, Zongshuai Gao, Xiang Ren, Zhufan Xu, and Changtai Zhu. \u201cPlatelet-Rich Plasma in Selected Urological Conditions: A Narrative Review of Biological Rationale, Current Evidence, and Limitations.\u201d <i>Translational Andrology and Urology<\/i> 15, no. 5 (2026): 182\u2013182. https:\/\/doi.org\/10.21037\/tau-2026-1-0084.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Javier, Angulo, Fern\u00e1ndez-Pascual Dr. Esa\u00fa, Curvo Dr. Raphael, et al. \u201c(219) AUTOLOGOUS PLATELET-RICH PLASMA IMPROVES ENDOTHELIAL AND TADALAFIL-INDUCED RELAXATIONS IN CORPUS CAVERNOSUM FROM PATIENTS WITH ERECTILE DYSFUNCTION.\u201d <i>The Journal of Sexual Medicine<\/i> 20, no. Supplement_4 (2023): qdad062.007. https:\/\/doi.org\/10.1093\/jsxmed\/qdad062.007.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Kanyilmaz, Gul, Hatice Halis, Ozlem Ay, et al. \u201cEvaluation of Sexual Life Quality and Vaginal Dose-Volume Relationship in Female Rectal Cancer Patients Treated with Pelvic Radiotherapy.\u201d <i>Indian Journal of Cancer<\/i> 63, no. 1 (2026): 76\u201381. https:\/\/doi.org\/10.4103\/ijc.ijc_764_24.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Masterson, Thomas A., Manuel Molina, Braian Ledesma, et al. \u201cPlatelet-Rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.\u201d <i>Journal of Urology<\/i>, April 30, 2023, 10.1097\/JU.0000000000003481. https:\/\/doi.org\/10.1097\/JU.0000000000003481.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Matz, Ethan L., Amy M. Pearlman, and Ryan P. Terlecki. \u201cSafety and Feasibility of Platelet Rich Fibrin Matrix Injections for Treatment of Common Urologic Conditions.\u201d <i>Investigative and Clinical Urology<\/i> 59, no. 1 (2018): 61\u201365. https:\/\/doi.org\/10.4111\/icu.2018.59.1.61.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Miller, Jake A., Muhammed A. Moukhtar Hammad, Lucas G. C. R. De Amorim, et al. \u201cEfficacy and Safety of Collagenase <i>Clostridium Histolyticum<\/i> in Men Who Have Sex with Men.\u201d <i>Sexual Medicine<\/i> 14, no. 3 (2026): qfag028. https:\/\/doi.org\/10.1093\/sexmed\/qfag028.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Moulis, Florence, Genevi\u00e8ve Durrieu, and Maryse Lapeyre-Mestre. \u201cOff-Label and Unlicensed Drug Use in Children Population.\u201d <i>Therapies<\/i> 73, no. 2 (2018): 135\u201349. https:\/\/doi.org\/10.1016\/j.therap.2018.02.002.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Narasimman, Manish, Max Sandler, Ari Bernstein, et al. \u201cA Primer on the Restorative Therapies for Erectile Dysfunction: A Narrative Review.\u201d <i>Sexual Medicine Reviews<\/i>, March 17, 2024, qeae012. https:\/\/doi.org\/10.1093\/sxmrev\/qeae012.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Poulios, Evangelos, Ioannis Mykoniatis, Nikolaos Pyrgidis, et al. \u201cPlatelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial.\u201d <i>Journal of Sexual Medicine<\/i> 18, no. 5 (2021): 926\u201335. https:\/\/doi.org\/10.1016\/j.jsxm.2021.03.008.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Queen, Dawn, and Marc R. Avram. \u201cPostprandial Lipemia and Suboptimal Platelet-Rich Plasma Preparation.\u201d <i>Dermatologic Surgery<\/i>, ahead of print, June 15, 2026. https:\/\/doi.org\/10.1097\/DSS.0000000000005214.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Raheem, Amr Abdel, Giulio Garaffa, Tarek Abdel Raheem, et al. \u201cThe Role of Vacuum Pump Therapy to Mechanically Straighten the Penis in Peyronie\u2019s Disease.\u201d <i>BJU International<\/i> 106, no. 8 (2010): 1178\u201380. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09365.x.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\"><i>Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff,<\/i>. n.d., 28.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Ruffo, A., M. Franco, E. Illiano, and N. Stanojevic. \u201cEffectiveness and Safety of Platelet Rich Plasma (PrP) Cavernosal Injections plus External Shock Wave Treatment for Penile Erectile Dysfunction: First Results from a Prospective, Randomized, Controlled, Interventional Study.\u201d <i>European Urology Supplements<\/i> 18, no. 1 (2019): e1622\u201323. https:\/\/doi.org\/10.1016\/S1569-9056(19)31175-3.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Runels, Charles. \u201cMemo in Response to the JAMA Article: \u2018Analysis of Direct-to-Consumer Marketing of Platelet-Rich Plasma for Erectile Dysfunction in the US.\u2019\u201d <i>Priapus Shot\u00ae<\/i>, May 3, 2023. https:\/\/priapusshot.com\/memo-in-response-to-the-jama-article-analysis-of-direct-to-consumer-marketing-of-platelet-rich-plasma-for-erectile-dysfunction-in-the-us\/.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Saleh, Doaa M., and Rania Abdelghani. \u201cClinical Evaluation of Autologous Platelet Rich Plasma Injection in Postmenopausal Vulvovaginal Atrophy: A Pilot Study.\u201d <i>Journal of Cosmetic Dermatology<\/i> n\/a, no. n\/a (n.d.). https:\/\/doi.org\/10.1111\/jocd.14873.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Sarna, Shiv, Karl H. Pang, Andrew N. Christopher, David J. Ralph, Asif Muneer, and Hussain M. Alnajjar. \u201cPlaque Incision and Grafting for Peyronie\u2019s Disease: 15-Year Experience and Functional Outcomes from a High-Volume Andrology Centre.\u201d <i>International Journal of Impotence Research<\/i>, ahead of print, June 1, 2026. https:\/\/doi.org\/10.1038\/s41443-026-01296-7.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Schirmann, A., E. Boutin, A. Faix, and R. Yiou. \u201cPilot Study of Intra-Cavernous Injections of Platelet-Rich Plasma (P-Shot\u00ae) in the Treatment of Vascular Erectile Dysfunction.\u201d <i>Progres En Urologie: Journal De l\u2019Association Francaise D\u2019urologie Et De La Societe Francaise D\u2019urologie<\/i>, June 10, 2022, S1166-7087(22)00130-0. https:\/\/doi.org\/10.1016\/j.purol.2022.05.002.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Searle, Tamara, Firas Al-Niaimi, and Faisal R. Ali. \u201cSaline in Dermatologic Surgery.\u201d <i>Journal of Cosmetic Dermatology<\/i> 20, no. 4 (2021): 1346\u201347. https:\/\/doi.org\/10.1111\/jocd.13996.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">\u015een, Serhat, and Feyza G\u00fclgel \u015een. \u201cPlatelet-Rich Plasma for Wound Healing and Scar Formation after Cesarean Section: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.\u201d <i>BMC Pregnancy and Childbirth<\/i>, ahead of print, June 11, 2026. https:\/\/doi.org\/10.1186\/s12884-026-09447-w.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Siroky, Mike B., and Kazem M. Azadzoi. \u201cVasculogenic Erectile Dysfunction: Newer Therapeutic Strategies.\u201d <i>Journal of Urology<\/i> 170, no. 2S (2003). https:\/\/doi.org\/10.1097\/01.ju.0000075361.35942.17.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Siroky, Mike B., and Kazem M. Azadzoi. \u201cVasculogenic Erectile Dysfunction: Newer Therapeutic Strategies.\u201d <i>Journal of Urology<\/i> 170, no. 2S (2003). https:\/\/doi.org\/10.1097\/01.ju.0000075361.35942.17.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Ta\u015f, Tuncay, Basri \u00c7ak\u0131ro\u011flu, Ersan Arda, \u00d6zkan Onuk, and Bar\u0131\u015f Nuho\u011flu. \u201cEarly Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction.\u201d <i>Sexual Medicine<\/i> 9, no. 2 (2021): 100313. https:\/\/doi.org\/10.1016\/j.esxm.2020.100313.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Tekin, Levent, Selim Akarsu, O\u011fuz Durmu\u015f, Engin \u00c7akar, \u00dcmit Din\u00e7er, and Mehmet Zeki K\u0131ralp. \u201cThe Effect of Dry Needling in the Treatment of Myofascial Pain Syndrome: A Randomized Double-Blinded Placebo-Controlled Trial.\u201d <i>Clinical Rheumatology<\/i> 32, no. 3 (2013): 309\u201315. https:\/\/doi.org\/10.1007\/s10067-012-2112-3.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Towe, Maxwell, Akhil Peta, Russell G. Saltzman, Navin Balaji, Kevin Chu, and Ranjith Ramasamy. \u201cThe Use of Combination Regenerative Therapies for Erectile Dysfunction: Rationale and Current Status.\u201d <i>International Journal of Impotence Research<\/i>, July 12, 2021, 1\u20134. https:\/\/doi.org\/10.1038\/s41443-021-00456-1.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Wang, Yi, Peng Luo, Ping Chen, et al. \u201cTrigger Point Injection: A Therapeutic Propellant for Myofascial Pain Syndromes.\u201d <i>Tissue Engineering Part B: Reviews<\/i>, September 29, 2025, 19373341251364757. https:\/\/doi.org\/10.1177\/19373341251364757.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Wong, Julie, Luke Witherspoon, and Ryan Flannigan. \u201cUnder-Recognized Factors Affecting Penile Implant Satisfaction in Patients.\u201d <i>Canadian Urological Association Journal<\/i> 16, no. 8 (2022). https:\/\/doi.org\/10.5489\/cuaj.7720.<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; text-indent: -0.5in; margin-left: 0.5in;\" align=\"left\">Yogiswara, Niwanda, Fikri Rizaldi, and Mohammad Ayodhia Soebadi. \u201cThe Potential Role of Intracavernosal Injection of Platelet-Rich Plasma for Treating Patients with Mild to Moderate Erectile Dysfunction: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.\u201d <i>Archivio Italiano Di Urologia e Andrologia<\/i> 96, no. 3 (2024): 3. https:\/\/doi.org\/10.4081\/aiua.2024.12687.<\/p>\n<h1 style=\"color: #b35e06; line-height: 115%; text-align: left; page-break-inside: avoid; orphans: 2; widows: 2; margin-top: 0.33in; margin-bottom: 0; direction: ltr; background: transparent; page-break-after: avoid; font-weight: bold;\" align=\"left\">Helpful Links<\/h1>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <a href=\"https:\/\/accma.memberlodge.org\/page-925782\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\">Next Hands-On Workshops with Live Model<\/span><\/u><\/span><span style=\"color: #0563c1;\"><u>s<\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/prp-training-runels\/\">=&gt;Next Hands-On Training with Live Models with Dr. Runels (includes marketing)&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\"><span style=\"color: #0563c1;\"><u><a href=\"https:\/\/botoxclass.com\/workshop\">=&gt;Hands On Botulinum Toxin Workshop That Teaches Medical &amp; Cosmetic Uses&lt;=<\/a><\/u><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <a href=\"https:\/\/botoxclass.com\/\"><span style=\"color: #0563c1;\"><u>Dr. Runels Online <\/u><\/span><span style=\"color: #0563c1;\"><u><i>Botulinum Blastoff Course<\/i><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/cellularmedicineassociation.org\/\"><span style=\"color: #c00000;\">The Cellular Medicine Association (who we are<\/span><\/a><\/u><\/span><span style=\"color: #c00000;\">) <\/span>&lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/procedures\/\"><span style=\"color: #0563c1;\"><u> Apply for <\/u><\/span><span style=\"color: #0563c1;\"><u><i>Online Training for Multiple PRP Procedures<\/i><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshot.info\/fsfi-calculator\"><span style=\"color: #c00000;\">FSFI Online Administrator and Calculator<\/span><\/a><\/u><\/span> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/5notes.com\/\"><span style=\"color: #c00000;\">5-Notes Expert System for Doctors<\/span><\/a><\/u><\/span> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt;<a href=\"https:\/\/cellularmedicineassociation.org\/password\/\"><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"> Help with <\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\"><i>Logging into Membership Website<\/i><\/span><\/u><\/span><span style=\"color: #0563c1;\"><u><span style=\"color: #c00000;\">s<\/span><\/u><\/span><\/a> &lt;=<\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/ontraport.com\/Cellular-Medicine-Association-\"><span style=\"color: #c00000;\">The software I use to send emails: ONTRAPORT (free trial)<\/span><\/a><\/u><\/span> <span style=\"color: #0563c1;\"><span style=\"color: #000000;\"><span style=\"text-decoration: none;\">&lt;=<\/span><\/span><\/span><\/p>\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent;\" align=\"left\">=&gt; Sell O-Shot\u00ae products: You make 10% with links you place; shipped by the manufacturer), <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/www.loom.com\/share\/dcd9fe2284a746a199fd7d5cc42d5f61?sid=f5a33b4b-a3ee-4fb1-b13e-2273718dce9b\"><span style=\"color: #c00000;\">this explains<\/span><\/a><\/u><\/span> and <span style=\"color: #0563c1;\"><u><a href=\"https:\/\/oshotwomen.leaddyno.com\/\"><span style=\"color: #c00000;\">here\u2019s where to apply<\/span><\/a><\/u><\/span><\/p>\n<div id=\"sdfootnote1\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote1anc\" name=\"sdfootnote1sym\">1<\/a> Garc\u00eda-G\u00f3mez et al., \u201cGrower or Shower.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote2\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote2anc\" name=\"sdfootnote2sym\">2<\/a> Raheem et al., \u201cThe Role of Vacuum Pump Therapy to Mechanically Straighten the Penis in Peyronie\u2019s Disease.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote3\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote3anc\" name=\"sdfootnote3sym\">3<\/a> Sarna et al., \u201cPlaque Incision and Grafting for Peyronie\u2019s Disease.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote4\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote4anc\" name=\"sdfootnote4sym\">4<\/a> Akarsu et al., \u201cUltrasound-Guided Aspiration of Baker\u2019s Cyst Combined With Intracystic Platelet-Rich Plasma Injection in Knee Osteoarthritis.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote5\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote5anc\" name=\"sdfootnote5sym\">5<\/a> Queen and Avram, \u201cPostprandial Lipemia and Suboptimal Platelet-Rich Plasma Preparation.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote6\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote6anc\" name=\"sdfootnote6sym\">6<\/a> Huang et al., \u201cPlatelet-Rich Plasma in Selected Urological Conditions.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote7\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote7anc\" name=\"sdfootnote7sym\">7<\/a> Hinojosa-Gonzalez et al., \u201cRegenerative Therapies for Erectile Dysfunction\u201d; Du and Liang, \u201cA Meta-Analysis and Systematic Review of the Clinical Efficacy and Safety of Platelet-Rich Plasma Combined with Hyaluronic Acid (PRP + HA) versus PRP Monotherapy for Knee Osteoarthritis (KOA)\u201d; Narasimman et al., \u201cA Primer on the Restorative Therapies for Erectile Dysfunction\u201d; Siroky and Azadzoi, \u201cVasculogenic Erectile Dysfunction,\u201d 2003; Javier et al., \u201c(219) AUTOLOGOUS PLATELET-RICH PLASMA IMPROVES ENDOTHELIAL AND TADALAFIL-INDUCED RELAXATIONS IN CORPUS CAVERNOSUM FROM PATIENTS WITH ERECTILE DYSFUNCTION\u201d; Anastasiadis et al., \u201cErectile Dysfunction\u201d; Siroky and Azadzoi, \u201cVasculogenic Erectile Dysfunction,\u201d 2003.<\/p>\n<\/div>\n<div id=\"sdfootnote8\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote8anc\" name=\"sdfootnote8sym\">8<\/a> Asghar et al., \u201cEfficacy and Safety of Intralesional Normal Saline in Atrophic Acne Scars\u201d; Bokey et al., \u201cHYDRODISSECTION\u201d; Bagherani and R Smoller, \u201cIntroduction of a Novel Therapeutic Option for Atrophic Acne Scars\u201d; Searle et al., \u201cSaline in Dermatologic Surgery\u201d; El-Amawy and Sarsik, \u201cSaline in Dermatology\u201d; Tekin et al., \u201cThe Effect of Dry Needling in the Treatment of Myofascial Pain Syndrome\u201d; Wang et al., \u201cTrigger Point Injection.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote9\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote9anc\" name=\"sdfootnote9sym\">9<\/a> Javier et al., \u201c(219) AUTOLOGOUS PLATELET-RICH PLASMA IMPROVES ENDOTHELIAL AND TADALAFIL-INDUCED RELAXATIONS IN CORPUS CAVERNOSUM FROM PATIENTS WITH ERECTILE DYSFUNCTION\u201d; Narasimman et al., \u201cA Primer on the Restorative Therapies for Erectile Dysfunction\u201d; Chung, \u201cA Review of Current and Emerging Therapeutic Options for Erectile Dysfunction\u201d; Ta\u015f et al., \u201cEarly Clinical Results of the Tolerability, Safety, and Efficacy of Autologous Platelet-Rich Plasma Administration in Erectile Dysfunction\u201d; Ruffo et al., \u201cEffectiveness and Safety of Platelet Rich Plasma (PrP) Cavernosal Injections plus External Shock Wave Treatment for Penile Erectile Dysfunction\u201d; Du et al., \u201cEfficacy of Platelet-Rich Plasma in the Treatment of Erectile Dysfunction\u201d; Anastasiadis et al., \u201cErectile Dysfunction\u201d; Chung, <i>Medical Sciences A Review of Current and Emerging Therapeutic Options for Erectile Dysfunction<\/i>; Schirmann et al., \u201cPilot Study of Intra-Cavernous Injections of Platelet-Rich Plasma (P-Shot\u00ae) in the Treatment of Vascular Erectile Dysfunction\u201d; Poulios et al., \u201cPlatelet-Rich Plasma (PRP) Improves Erectile Function: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial\u201d; Masterson et al., \u201cPlatelet-Rich Plasma for the Treatment of Erectile Dysfunction\u201d; Chung et al., \u201cRegenerative Therapies as a Potential Treatment of Erectile Dysfunction\u201d; Hinojosa-Gonzalez et al., \u201cRegenerative Therapies for Erectile Dysfunction\u201d; Francomano et al., \u201cRegenerative Treatment with Platelet-Rich Plasma in Patients with Refractory Erectile Dysfunction\u201d; Matz et al., \u201cSafety and Feasibility of Platelet Rich Fibrin Matrix Injections for Treatment of Common Urologic Conditions.\u201d; Hu et al., \u201cThe Effect of Platelet-Rich Fibrin on the Biological Properties of Urothelial Cells\u201d; Yogiswara et al., \u201cThe Potential Role of Intracavernosal Injection of Platelet-Rich Plasma for Treating Patients with Mild to Moderate Erectile Dysfunction\u201d; Siroky and Azadzoi, \u201cVasculogenic Erectile Dysfunction,\u201d 2003; Garcia et al., <i>Treatment of Erectile Dysfunction in the Obese Type 2 Diabetic ZDF Rat with Adipose Tissue-Derived Stem Cells<\/i>; Towe et al., \u201cThe Use of Combination Regenerative Therapies for Erectile Dysfunction.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote10\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote10anc\" name=\"sdfootnote10sym\">10<\/a> Wang et al., \u201cTrigger Point Injection\u201d; Tekin et al., \u201cThe Effect of Dry Needling in the Treatment of Myofascial Pain Syndrome.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote11\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote11anc\" name=\"sdfootnote11sym\">11<\/a> Runels, \u201cMemo in Response to the JAMA Article.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote12\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote12anc\" name=\"sdfootnote12sym\">12<\/a> Moulis et al., \u201cOff-Label and Unlicensed Drug Use in Children Population\u201d; Commissioner, \u201cUnderstanding Unapproved Use of Approved Drugs \u2018Off Label\u2019\u201d; Beitzel et al., \u201cUS Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine\u201d; Hames and Wynne, \u201cUnlicensed and Off-Label Drug Use in Elderly People.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote13\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote13anc\" name=\"sdfootnote13sym\">13<\/a> Beitzel et al., \u201cUS Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine\u201d; <i>Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use; Guidance for Industry and Food and Drug Administration Staff,<\/i>.<\/p>\n<\/div>\n<div id=\"sdfootnote14\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote14anc\" name=\"sdfootnote14sym\">14<\/a> \u015een and \u015een, \u201cPlatelet-Rich Plasma for Wound Healing and Scar Formation after Cesarean Section.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote15\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote15anc\" name=\"sdfootnote15sym\">15<\/a> Chaudry et al., \u201cNeuromodulators for Facial Aesthetics.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote16\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote16anc\" name=\"sdfootnote16sym\">16<\/a> Miller et al., \u201cEfficacy and Safety of Collagenase <i>Clostridium Histolyticum<\/i> in Men Who Have Sex with Men.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote17\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote17anc\" name=\"sdfootnote17sym\">17<\/a> Ajeet Singh and Redmond, \u201cComment On.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote18\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote18anc\" name=\"sdfootnote18sym\">18<\/a> Cocci et al., \u201cPenile Prosthesis Implantation\u201d; Wong et al., \u201cUnder-Recognized Factors Affecting Penile Implant Satisfaction in Patients.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote19\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote19anc\" name=\"sdfootnote19sym\">19<\/a> Kanyilmaz et al., \u201cEvaluation of Sexual Life Quality and Vaginal Dose-Volume Relationship in Female Rectal Cancer Patients Treated with Pelvic Radiotherapy.\u201d<\/p>\n<\/div>\n<div id=\"sdfootnote20\">\n<p style=\"line-height: 115%; text-align: left; orphans: 2; widows: 2; margin-bottom: 0.14in; direction: ltr; background: transparent; font-size: 10pt;\" align=\"left\"><a style=\"vertical-align: super; font-size: 0.85em; font-weight: bold; line-height: 0; color: #0563c1; text-decoration: none;\" href=\"#sdfootnote20anc\" name=\"sdfootnote20sym\">20<\/a> Saleh and Abdelghani, \u201cClinical Evaluation of Autologous Platelet Rich Plasma Injection in Postmenopausal Vulvovaginal Atrophy\u201d; Chen et al., \u201cPlatelet-Rich Plasma for Genitourinary Syndrome of Menopause in Breast Cancer Survivors.\u201d<\/p>\n<\/div>\n<div title=\"footer\">\n<div id=\"jcpm-post\" style=\"font-size: 1.1em; line-height: 1.55; color: #222;\">\n<div style=\"border: 1px solid #ccc; background: #f6f6f6; padding: 14px 16px; margin: 0 0 22px 0; font-size: 0.82em; line-height: 1.5; color: #333;\">\n<p style=\"margin: 0 0 8px 0;\">This page is intended solely as professional education for licensed healthcare providers. It is not medical advice, not patient-directed advertising, and not an offer to treat any individual. Nothing here should be used by a member of the public to diagnose or treat any condition; patients should consult a qualified, licensed physician about their own care.<\/p>\n<p style=\"margin: 0 0 8px 0;\">The procedures and platelet-rich plasma (PRP) applications discussed are investigational and\/or off-label. They have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for the uses described, and the FDA has not approved PRP or these procedures to diagnose, treat, cure, or prevent any disease. References to the O-Shot\u00ae, P-Shot\u00ae (Priapus Shot\u00ae), Clitoxin\u00ae, Vampire Facial\u00ae, Vampire Facelift\u00ae, and other trademarked procedures describe training methods and clinical approaches; they do not imply FDA clearance or guaranteed outcomes.<\/p>\n<p style=\"margin: 0 0 8px 0;\">The content reflects a review of the published literature and the clinical opinions and experience of the author. Comparisons to FDA-approved drugs or surgical options (for example, references to a procedure as \u2018first-line\u2019) represent the author\u2019s interpretation of the cited studies and individual clinical judgment \u2014 not established medical consensus or proof of superiority, safety, or efficacy. Individual results vary, and no specific outcome is promised or guaranteed. Statements regarding the absence of reported adverse events reflect the limits of the available evidence base and should not be read as proof of zero risk.<\/p>\n<p style=\"margin: 0 0 8px 0;\">Any clinical decision remains the sole responsibility of the treating licensed provider, who must exercise independent professional judgment, obtain appropriate informed consent, and comply with all applicable laws, regulations, and standards of care in their jurisdiction. The author and the Cellular Medicine Association assume no liability for actions taken based on this information.<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>JCPM2026.06.16 The following is an edited transcript of the Journal Club with Pearls &amp; Marketing (JCPM) of June 16, 2026, with Charles Runels, MD. &gt;-&gt; The PDF of this live journal club can be seen here &lt;-&lt; Topics Covered Showers vs. Growers: Penile Proportion, the Tunica Albuginea, and the Penis Pump Draining a Baker Cyst [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[227],"tags":[2115,2113,2100,2101,134,311,2105,264,2106,316,330,2094,530,2102,2031,89,828,221,2103,2088,2112,381,2114,2104,40,2107,30,65,968,340,2109,1368,1163,2099,2098,2095,157,228,249,68,896,2110,611,2097,2093,916,328,2096,2108,2111,167,531,329],"class_list":["post-5131","post","type-post","status-publish","format-standard","hentry","category-peyronies-disease","tag-5-notes","tag-ai-marketing","tag-baker-cyst","tag-bartholins-cyst","tag-botox","tag-botulinum-toxin","tag-c-section-healing","tag-cellular-medicine-association","tag-cesarean-delivery","tag-charles-runels","tag-collagenase","tag-comma-separated-and-ready-to-paste-prp","tag-corpus-cavernosum","tag-cyst-drainage","tag-daxxify","tag-dyspareunia","tag-dysport","tag-erectile-dysfunction","tag-hyperlipidemia","tag-informed-consent","tag-investigational-therapy","tag-journal-club","tag-large-language-models","tag-lipemic-plasma","tag-o-shot","tag-obstetrics","tag-off-label","tag-p-shot","tag-pde5-inhibitors","tag-pelvic-floor","tag-pelvic-radiotherapy","tag-penile-curvature","tag-penile-fracture","tag-penile-fracture-repair","tag-penile-proportion","tag-penile-traction","tag-penis-pump","tag-peyronies-disease","tag-platelet-rich-plasma","tag-priapus-shot","tag-prp-preparation","tag-rectal-cancer","tag-sexual-dysfunction","tag-showers-vs-growers","tag-tags-for-jcpm2026-06-16","tag-testosterone","tag-trimix","tag-tunica-albuginea","tag-vaginal-delivery-recovery","tag-vaginal-dryness","tag-venous-leak","tag-xeomin","tag-xiaflex"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p6W8NG-1kL","jetpack-related-posts":[{"id":3135,"url":"https:\/\/oshot.info\/members\/jcpm2023-12-05-peyronies-birth-control-pills-sexual-dysfunction-prp-devices-serious-warning\/","url_meta":{"origin":5131,"position":0},"title":"JCPM2023.12.05 Peyronie&#8217;s | Birth Control Pills &#038; Sexual Dysfunction | PRP Devices (serious warning)","author":"Charles Runels, MD","date":"December 10, 2023","format":false,"excerpt":"Topics Discussed Include the Following... Penile Rehabilitation after Prostate Surgery (new research supports the use of our P-Shot\u00ae procedure). Research on Platelet-Rich Plasma (PRP) in men in the bedroom The Role of Testosterone in Women's Sexual Function and the Impact of Birth Control Pills The Use of O-Shots\u00ae\u00a0in Improving Female\u2026","rel":"","context":"In &quot;warning&quot;","block_context":{"text":"warning","link":"https:\/\/oshot.info\/members\/category\/warning\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/vampirefacelift.com\/members\/wp-content\/uploads\/2021\/08\/O-Shot_Oil_bottle-300x300.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":5021,"url":"https:\/\/oshot.info\/members\/jcpm2026-06-02-why-p-shot-is-likely-best-first-line-treatment-for-peyronies-disease\/","url_meta":{"origin":5131,"position":1},"title":"JCPM2026.06.02 | Why P-Shot\u00ae is Likely Best First Line Treatment for Peyronie&#8217;s Disease","author":"Charles Runels, MD","date":"June 15, 2026","format":false,"excerpt":"JCPM2026.06.02 The following is an edited transcript of the Journal Club with Pearls & Marketing (JCPM) of June 2, 2026, with Charles Runels, MD. >-> The PDF transcript of this live journal club can be seen here <-< Topics Covered Every Week I Look for Bad News About PRP \u2014\u2026","rel":"","context":"In &quot;Clitoxin\u00ae&quot;","block_context":{"text":"Clitoxin\u00ae","link":"https:\/\/oshot.info\/members\/category\/clitoxin-r\/"},"img":{"alt_text":"","src":"data:image\/jpeg;base64,\/9j\/4AAQSkZJRgABAQAA3ADcAAD\/4QCMRXhpZgAATU0AKgAAAAgABQESAAMAAAABAAEAAAEaAAUAAAABAAAASgEbAAUAAAABAAAAUgEoAAMAAAABAAIAAIdpAAQAAAABAAAAWgAAAAAAAADcAAAAAQAAANwAAAABAAOgAQADAAAAAQABAACgAgAEAAAAAQAAAYOgAwAEAAAAAQAAATQAAAAA\/+0AOFBob3Rvc2hvcCAzLjAAOEJJTQQEAAAAAAAAOEJJTQQlAAAAAAAQ1B2M2Y8AsgTpgAmY7PhCfv\/AABEIATQBgwMBIgACEQEDEQH\/xAAfAAABBQEBAQEBAQAAAAAAAAAAAQIDBAUGBwgJCgv\/xAC1EAACAQMDAgQDBQUEBAAAAX0BAgMABBEFEiExQQYTUWEHInEUMoGRoQgjQrHBFVLR8CQzYnKCCQoWFxgZGiUmJygpKjQ1Njc4OTpDREVGR0hJSlNUVVZXWFlaY2RlZmdoaWpzdHV2d3h5eoOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4eLj5OXm5+jp6vHy8\/T19vf4+fr\/xAAfAQADAQEBAQEBAQEBAAAAAAAAAQIDBAUGBwgJCgv\/xAC1EQACAQIEBAMEBwUEBAABAncAAQIDEQQFITEGEkFRB2FxEyIygQgUQpGhscEJIzNS8BVictEKFiQ04SXxFxgZGiYnKCkqNTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqCg4SFhoeIiYqSk5SVlpeYmZqio6Slpqeoqaqys7S1tre4ubrCw8TFxsfIycrS09TV1tfY2dri4+Tl5ufo6ery8\/T19vf4+fr\/2wBDAAEBAQEBAQIBAQICAgICAgMCAgICAwQDAwMDAwQFBAQEBAQEBQUFBQUFBQUGBgYGBgYHBwcHBwgICAgICAgICAj\/2wBDAQEBAQICAgMCAgMIBQUFCAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgICAj\/3QAEABn\/2gAMAwEAAhEDEQA\/AP6Mr1M5HT3rkb1cKwBrrL5uSPrXIX25gcZ61+F1D9UpbnJ3ZCggGuencYzn8K3b1SMrg881zk48sjNcstzsGLLtb8R1NRXmpQW0qxysASM00yDHA\/z+VfOfxb8SX+l+IbWK2yVI2kivkOOMX7HBuaWzR35bR56vKe6+JIk1jQJ7WLDEoMe9fIfhvw09h41j1hFO9W2uMY3AcV9D+D9YkurNHnJ+ZRkGtmTStLkuWvIgFcnLe5r80pYv2sFNHoVqHLLlZ1HiTxbF4Y8JSairbD5ZYDPTiv5af+Cgnx81f4h+LG8F2chMIYtMF54B4Ffvh+1B4ubQvAjxwnA8orx61\/MhqXhbWPHnxYubhVZxLeLHxzhc10qEpxtE+K4xvKiqMep9W\/CT4Sra\/C+1vWjZWFqGbA7sNxP61+bvibw1DrHj\/UrjbwLl1TcOy8V\/SdB8P7Pw18GGuQioIrEH05CDrX4RW2ji71m\/1WFCVNxKSw7ncaxzCnOE4qD30+R8VnWB9nhqcWfIXxHuk0GxMUeFwMHH0rM\/ZF0eLxR+0DplxdnbFBIZ3c9gMc1o\/Ebwv4h+IXir\/hGvDUDSy7vnwOEHqa9z\/Zl+Avjz4d+ObjXPEMBSKOFEhlIIG52J78V9XlKhh8DJc\/vSPIyjBz9rCSjpdfmfvl8ePit4S8I\/Aa9CyRKi2XlbiVGeMd6\/krh1yDVvG95dR5Ed1eSyBuCPmYnPFfpb+234n8S6h4QsfDL3DrDdXKoyK3Lqg3EHtX5+6N4QSwv7SKRQFdhlgOQcVthsRSjRm5vV6fcevxDmTqYmEEtj6I0HTLF\/D7S3O3eBlGA5rxfxhqcy3q2oc7TnPuBX1V4f0i2h8L3MkqEBVO0u2SAO+K+UPG7WE1+JImXdj5wP0rx8FhbVVNovE4dwjKR6x+yrr40b4pJGr4SXB688V\/R94qvk1z4Jq4ILLHg5OeNtfy1\/Bu4ktfihYSQnGWr+lLwVfnVPhU+nyNk+UMflX00nypRPS4anzUpI\/nM\/aBsV074i3bkHLHeD7g1+6X\/BN\/xNqMmhaclyz5Mag\/pX5L\/tceBru08Tx6qqARtP5chHoxxX7If8E\/8AQ44dEs2QDCxrj24H864oRtaPVXNcqwso4qaP3t8H3K3ESt6gcV9I+GZCEAxivmHwDE8cAZj6cV9GaBOBxXfh2fUVUeuW75jBp17b\/arZ4B\/EMfnVCymBjAz2rUXPQV6e5inY\/Nz9oP8AY\/0z4tX6yajDuVXLbiM+1eSeHf8Agnx4Y0tVjitEwD\/dxX6\/tEknLc1KlpH6c1xSy+nLdHfSzCpH4T85dG\/Yr8PWWP8ARUGMdq9Q0v8AZY0KzwViQEd8c19sx2yelXEt1P3FOPXGalZVR\/lNHm1d\/aPlax\/Z90a2wAi\/hxXXad8HtFtnVyoyvTivfGtz2Q\/lVZ0KHB4raOX0Y7RMJY6q92Z2j6db6RaiCAYA4HGKsyyE0rPjpVcv83oM10cvSJyXvq2c1eadcakHiiB\/1h\/Cu707RtcluIck7doGVH+zXESarNpdwynIUnII\/E1sWvxWFmIyquxRcHP8VfEY\/DzWIcrHu0aidPc9Dt\/Alxa3EFzub5ZlbPvmvSvG5MXhiYSf88xnNfP8\/wAaZiqpDG5BbLDBq1qfxFm8QaebVVZQwCndXsZUuSUrRtc4MZeSWpz7SkHmkaQgVmmZc8HPtTTMM8ce2a9k880PNOc0sko8pvpWWZgKjkn\/AHLZ9D3pqVhobf2FpqNuRcKCNuM\/hXA2egafbx7lUd+nSu6FwfswCn+E\/qMVxU2oR2tnJMx+6CK+5ySpbDSPawdFylB+ZwOv2unQyLIiIGEinI7YNfs\/8B5hc+CbV+M+QoBH0Ffz4+Mvi94as9RNlNMqOG+6SBX7X\/sm\/Efw\/wCIPBltDbXKO\/krwGz2Fe9wpjl9Y5Ti8RsudOhSn5n2TMgaEqevNcVMjLcg5711017bohZnHT1rib\/WtNtm82SRRjk5NfqDmktz8Rxs4+7dncQuPKX6VLvWvPY\/iH4dVAv2iLgf3v8A69P\/AOFi+Hf+fiL\/AL6\/+vWXtodxLEQ\/mP\/Q\/ozv23HpmuRvVYqe2eDXX3rE7ulcjeN15z3r8OqxsfqlN6nGXqsSQSelc7c9efeuk1HKsTjt1rmLo7uR6VxS3OwoyMrIQBXzX8aIo49VsppcDnBJr6OlPUV8+\/GvS7i\/ktJYASFIzivj+PYt5dOyuepk3+8IdoGpi3swI26DA\/EVpx65dkFScc1xGiWt1DAiSc\/L+VdPFbSZ+YV+RYG\/skme7i7c9z58\/akW71DwirLuIOP514d+zN+zFbav4hXxF5CyLK\/mkkDIJ6ivtD4oeFzrfhRkRd7R87cdRXq\/7Kvh2bQ1SC6iwjYIHpX0mVO\/us+ezLCqTu0ec\/tAeDD4X+FN9pDLtVrYhSOONp4r+auz8R6PpNvfWMzRr5UswcHqSDX9PH7e\/jbTPDnga7QsAEt3647A1\/HdqryazPqmt7mVJp5XUA8cmlmeVSrV4KOyPhuIcfTouLe59E\/sj+IPDt78TdR+zWf2qW6ujEr7eI1BGBk1+wniH4I6tqPg+Z4bYbpgrMABtBUfL0r4N\/4JVfC\/QPFGrf2pqCfvDdvyccgNX9UPiDwR4Z0bwAYrKBd4g5YgDtXuQw69lbsd2SUlOhGT0ufxG\/tW6ZqVt42sNFv1I8jzXKnoCCBmvnXxGLWGKJ0IBTBA75r9H\/24\/CEs\/wAZJLlV+Xy2AHpzk1+Z\/ii3k\/4SS301jwz8Yz2r4yjifb4lU0\/hPh8zw7hjPe7nVvq17deHW8qYr8hG0ZyfrXy3eWWpR37yckOxIzX2pJoNvb+H57ibJZYtwUdM14lf6ZDIUkKn5hkkc19XTxsqEveV00ehnuHfs4yi+hmfCqOLSPFNtql6QoBABPav21+E3xe02fT49HMisWUD9K\/FU2SpbHy0bjow9favXvgr41utM8V21pcSkAuqgMc96rDY+VSepz8O432cvZyPqf8Aa9axm0qa7wOXBHtg1+h\/\/BPK8Sfw1YEkHdEpJr4Z+Mngufx94bkgtRubaCWHTJ5r7e\/YO0C+8N6NZ2twpzGoXn2rtlSftXI+voRk8Q5PY\/eDwlIiQKqe1ez6NPghh0r508J3zPGmPY4r3LRJ2ZQTxxXcnZ3PXlDse3adcKYwM1vRy\/lXB6XdKsYBI6V0cN1H6+ldyd0c0o6nSIwFZviPxd4d8GWH9p+I7pII+do+9I5H91RkmsbWvFGn+HdLk1S6+fYNsUaEbpJG+6i+5\/TFfCnxD1TV\/E13\/aWsTiS5lLJDEDiOJAfuovoPXueTXQ720PpeHcgeMmm37vV9zsvH\/wC2Jq6TtY+A7OKFRwtxdjzJWGeoQYVfxr5I8S\/tA\/GfU2a41TxJqFuSciC2KxKBzx8gqDV7E6fO0k0ZbJxgD+9159sV87+PLvUZppGt4nCrjdswOPw9K8qtVqN7n7llfBWDgkoQudzqHx6+MNm5ntPE2otluA875\/niqGn\/ALYPx30K7Up4gvXCn5lm2Toceodf618q61f34xJIGRWkwEZs8jowxng1zGrT3V3EIrgoVjHKxHkyDqN3bHHT8qxjVn3PTxHB+EktYL7j9R\/B3\/BSjxXp0ixeNLKz1OIMAzWsZgm9z1ZSfbivvf4RftY\/Bn40zDT\/AA3qDW2o7QW07UFMMuemFYjY\/PHBzX8zejnUrxIheIY5NpbG\/ftPOBuAANeseGddk0CWHWLN2DghtyH7jLyefqBXo4Wpfc+Iz7w\/w\/K\/Y6SP6lpfLfImUH1zWbJFbKOI0\/IV8G\/sy\/tWweOjB4D8TSgagy4sJpG5kP8AzyLHGT\/dP4elfaMl5fuTsQ4BrtlTfY\/GcdgKtCo6dRWNo+VjgD8qheVQKxidQbjbj60n2e+K89aHRlbRHC+xbe5GfvfrTPtA\/vD86pjTb1u5qwNBvZMNzx9aUcJNrYppLqSC4GfvfrRJOpibaexqZPD1yvBqVdBnGc1f1Gb0IujHW+SGAIwYkjjbXAa\/LLc6PNHZQs8u1uDxzXraeHZQc9aQeGZP4lzz0r2cHUqUqbp8t7npUczVNLTY\/mu\/ax+Hn7SOpeKDf+B9OueJT9xuCue\/Iruf2bfjh+358E1jSHQ5r6FcYSVtpGPfJr+hQeDLWQ5eCNj6soatCHwfaR8CKMD\/AHBWtOrU6RsebnmIljZy556Pofm+3\/BQP\/goDrECQweDbe3A27t0zFiO4GOhrpbv9rb9srVvDzpH4UlF60Z2xmUbNxHGWJHHev0Jj8MQddqj32irI8Nx9gPqBXZHGYxK3Oz5KXDOCbvZn4bX3iv\/AIKfX95JexLZwrK5dYhyFB6DO+qv\/CQf8FQf71p\/n\/gdfuqfD7A4Cj\/P4Un\/AAj7f3P8\/lXNy4j+dnWsiwv8p\/\/R\/ozujwV71yl8EXPJOfaulvXPQc1yV1IzZ44B4r8QrH6nTRymoun3V78GuVvXCDg10d+m5\/mOO\/FcpfFVbPbBxXFUOuOxiTyknIHQdq57W7eG\/tkMwyQeK1ZnxnkVTmjmuolS3Uu2egryOIKSnhpo6cPK07nJra28Q2xqPWpoo1U5wB9a7Wy8D61qJHlxPycYx2rudN+DWuXWC0T\/AJV+YwyWtP4YHqzxMV8TPJ7aOC7kFpOAyMcHjNfQHgvTdN0Oza5j2jauenSr9j8CdRjZZGRhivQIPhdqItGtSGwy4Oa9rA8O4iLvynBiMfTasmfzv\/8ABU34vSHS5\/D1mJXedfLVY1LZyT6V+Fg8GeMrzwo407TrrLIcbo2GTX9uvjL9hzwl481BNS8QwRzMrBlV1B5rU0z9hH4c20S25sIjGP4Qgx\/KvqsPlFVQs4anwGcZLHF1eeU7H89P\/BKXwf4m8NWduNdsLi2k3ljvXAO49etf0X+LL64uPDbWtupLtFtH1xXpPhD9lrwb4PKtpdoiY6BVC9\/YV6oPhpCV2vGSPQiiPDNZxcX1PewNaGHpxgnex\/Lt+0n+yd8U\/iX4ylv9IjRFO7a+wnANfG8H\/BKT4za\/4it9V1C8aNIj0jhGTn3Jr+1Ffhbp6nP2aPPqU5q0nw3tIxlIFB9lrz8J4fqnUdRbs48ZRw1aopz3P5StP\/4JK+ItT0s2mq3d0+9QDg7f5V0Fj\/wRy0SNY1ujPJt67nYV\/U0fAZ27VQDPHT\/61Zj\/AA7lVslTXr1OE5PeJpKWGkveR\/NVZ\/8ABHjwcItr25PXGWJ6\/jVzSf8AgjR4Ks9Ui1OGAo8bZyG7\/nX9KkXw\/kPBTPtWlB4EZefLrWjwe1qomfLhYu6ij8dfCH\/BPjwjotgLS5iVuMEOMnp+Ne8+EP2TvDXhWNV06FECdAqjqa\/Su38CsSDtArcg8Bjb05zXqLhab3Oj+04rRI+IdO+FKWQURKQRxwMdK7S08C3MJGASM9q+vovBCDgj9KvR+DIFPPT0rphwm+xk82XQ+WbXwleooKAj61qR+GL4YBByegzX0+nhGADGKxvFGkWvh\/w7eaxLtHk27Mmehc\/Kox3+Yiun\/VflV2THM1KSiup8EfED7VLdmXOYbQMkI7PIeGb27AHtXhtzE1xIgutqsQFHy5OW96+rdcm068tE0m5CtIsZ+UnBJ\/vH6182+Mre5tLyB4mwFKrgEYZwfTnjFcONyuEF7p+68LT5aSppbHkPinw8sD4nMn71ScRkFcd8HGB+VfLvjDQVtsMiyFJImCsW+6OhzkAdhjNfcfi3z7yBfssKltgePII+v49xk18jeMPBt1dXZvr3coVw4EpPAI6ccHrmvmsbQS2R+mZHXk4u58v+LdFlht4LUrbTKYifMBAbdjsM8ehrwbxJDdWSILRTEqOrCVgCCuDuUY\/iBxzX0j4+0vXJdSK2+1zAi+WAg+f1BC85A9a8C8Ywah9khE8atCn3ljYnDDpnPPX8K8v2Dvex7v1mKSuzz6z1UzMbi0YM4TaFJ+UnPIOOOOcmu207X7C5Mump\/rofluYsHCiTkMD0K9s9u9cTa2Vm75ii8tRhRIAMHPcbeR3BPOa6iwtFisvMG0uiGJZFGWG89x6ZBHTit4Kxx4qMZptHqfhPXJtF1e3uYJXinjlWWCVTj50PBBHQg4r+k34G+K7P4t\/DDTPGqbTPNGbe\/VcDbdw8SjHoeGHs1fytxatPYODcgMySAqgyST3APXOK\/Zf\/AIJ7ftZ\/Bn4e6fqng34oa\/babDqD289k1wHKJcLmNlZ0VgmUIyWIHy5r3clnCdT2dSVrn5J4g5DUrUVWw8HKS7H61x6IgONmPSp\/7IiTjb2r1nS4dD1ezh1PTZ4ri3uIlmhuIWWSORHAIdWUkMpHQirN1penRryw5+lffrh7S97o\/nqeZNNxnFpre55FFo6udyqDWlHokjHaE9+leoWen2ITk5\/ACttLSzj5\/nitafD8bK7MJ5k+h4\/\/AMI7dMf9WPyo\/wCEcmHHl\/pXtSzWMa\/w\/hTTdacOSAfoK6VkFLuYSzKR4sPDtz2T\/vmrUXh24xu2N+VevnUNMA+6v5Ui6ppijOF\/L\/P860jkVFbyJeYT7HlK+Gpjzt5NP\/4RmfpsNeoDW9P7bR+FIddsh2H5VqsmoL7Rk8fU7Hmg8Mzj+E\/lTj4bmAyVb8q79tes2bbtHvUL69ZH5cDjjpVf2TR7j+uVG9EcIPD7ego\/4R9vauxOs2We3+fwpP7Zsvb\/AD+FT\/ZVHuX9bqdj\/9L+im9YKCfbn2rlLmRea6C+mQA5I5z3rlryWIA4bmvxGrHc\/VKZy+oEktnj0rj7znANdTeyKxPIP41y94ufQY9DXFPY7DlLw7c9ua93\/Z08K2fjDXZra5AcRqCAa8D1AqMgn8K+o\/2NruFfG9zBIV5jU0qNJTmoy2ZliG1Bs+4tK+FulWSBEiXgdcA119v4JsoUAEa4+gr0EyQx9SKRbu3HO4H619Ph8vow2R8nVxdRy3OMPha1HASnp4UtgNxQ\/lXXPfw5wGXrTX1KMLjKgV3wo0rbGEqs9rnIP4eth\/Dx+FINEtozjb09q2bjVbcdSM1jtrcSkljxih8i6ApTetycaPbAfMB+lRtpkCjKgfpVCfxJaAhSw9hUJ12AjdkYPGBT9rTWyFKnPqXv7PgB6fpVd7SEHgD\/AD+FZra6F6FcGqsmtxhsM49sVLxMOw\/ZPuarWsWcYqN7SLrtzjtxWHLr0IHDfjVCTxCgXDN\/n86X1mJSoS7nUJFaoORyPapP9EUcAfjXncviaJScOB+tZdx4xjQH56pYuInh33PVWubccKAKf9vhC14TceOYwwDPVF\/H9sM5lA+lH1\/omJ4V7n0KNRhXB5qJtVjB4r50f4h2w48z8c1mTfEa3Q\/6wn8aX9pJdRrCX6H08mrozZyPzry\/41akZvh\/dRQE\/wCvtyw9VEg\/rivKT8TISOHxz61ieJPGtpr+h3Oku4xNHtU5+6w5U\/gcVjVzFOLVzrwOG5a0JNdTxLV7md7oXdqBsZWR2XiVnyPu9guO9eFeJNMuJr3\/AFjRsZAQA2SpzgD29zXoHi34k+G\/hl4Zm8ReJJFTzcxoh9E+8QOuMjPA56V+V97+2LdeItfv\/sK7YFkcW6xr8xUHKkdT+Yr5bMZXSdz+jeHmmrwR+j+v68NB8NySXBX7QsWxix3YcdRk84xz0r8sv2hfj94ptZF0HwbZm5mkTpFjhs9GPBx3zya+qtO1fUfi78Op9VE7xNaL+9wcP8wzlvryK\/NuX4ov4Q8W6nZaLpz3+opazm0dwZdkucI7D0z0HrXjOpeai\/xPtsLL2dGTp73JYNR+JmneHw2uXP2C5mBadriZI3bcchUVjuA7Z\/SuHi8ajVr9tLvWW\/GQjR8SbJFIwQQMjp1HWsK\/\/Zu+JnxN+Gk154wvNUs9XvL8yh7WZiJLRh+8klaIhvOLn5ELbEUAYzzWj8Mf2LLfwhew3mnXHiAR20m66vr+6kDOP7saNuAXOc9T7124rAQjRVTnV30X+Z42GxVaeIlSVP3e99\/Q7S20UtdFUZ49yliiA7gBz\/n2rV02eP8AtZrKbY1xEi+egOGRWJwGPTDDlfy7V634h8ES2+ll7hgHWNoFaFiDtb7pIb+Lp9a4KHRGisoozIryoB87\/eIQ4+Yr1OR37V8vUnqfc0KDpwXMclrelf2i39j27GL7VlHmjHKxsfmI98cDHrXk3xE0y0i1\/S\/C2ktbxusEn2WzCs0kqr8rZII5yBliepHGa9uktWtb2OSx8wvbSeaz\/wBzPHODyCh5rz\/4reAviHd3a\/EnwTexlNLt3fUNIkjGLgM+SyvgsrrkYwcEDkdKKdO7ue1kVf2U+VWV+rP1m\/4JH\/tUeI7jVtR\/Zw8ZzzGOHzJtGjuWLSWk0ILS24J5KSKCy+\/1r90bvVCXC7+vTP8Ak1\/Jh+wt410zUv2nPBvxF03dHc399LoutqTgpdRqShPXnCspHvX9IWp+NjbyAs\/A75r7rh3NZyock3sz+b\/H3h2jh86VajDl9pFNpbX6s+o7XVEiGC4zVy51lPKwHH518izfE0IoIcdPWo\/+FlGdNob3619Iswfc\/C\/qZ9VNr0KjG8U4axGy7i4618mr46Z2xvA56d6sS+PRCoUuPzp\/XxPCn1BNrdumRvH51SOuR9mH518qN8QpDIcNjmop\/H2Dndz9abx6E8Kz6jn8Q28Z3M44681TTxXaseH\/ADr5NuviDuUgSAde9ZUXxEiQYeQE\/WsvrupX1Rn2T\/wk9ruPzj6Zpv8AwkdtuADD8\/8A69fHDfEi2TDeYvHvSJ8TYMkmRT071Sxl9xfVGfaY1+2x1\/X\/AOvR\/b9t6\/5\/Oviw\/FO1yczJ+f8A9ek\/4Wnaf89k\/P8A+vR9bQ\/qcj\/\/0\/qR\/wDgrT+z1MuZEvk45zEwrmbv\/grf+y8jFZrqdT6Mjj+lfzw3vlx2TnaPu96+XfFMoTVAiYwxzjpX8yZfxJia0rOx\/VWacGYShG8bn9Yei\/8ABUj9m3xRqQ0rSLyR5jwFCt\/gK+qfD3xf0Dxvp41DR2fYwH3uOtfxx\/s+xI3xAj3jLZHP41\/UB8AVC+FIgvHyqT09K83OuJ69J2VjwMTklKC91n1pbyzaxcrbQyYLnHzV9k\/s6+CLrwh4jTxPdXKbSgBTPXqa+FbeR4mWWM4KtkGvStH+JusaTCE8xhtxgZriwPGkuZOsrHh4jA3i1A\/ZG+8eWYQssi4wOa4+5+JtrESPNQc9zX5b3Px01cqY3kb8DXnmt\/F3xBcMTA78n1r35cdUt7nlRyBt6n64TfFeyXJE6ce9U\/8AhbVkchp0\/MV+Nw+KHihpFQu2CccmvTNF1vX9RtWnaRsBC33vSlR46hJ2Q55Bbc\/STUfjDp0alxPGf+BDpXH3Pxt04E\/6Qn4GvyU8H+O\/Eniz4mXnhkykm2dV2Z4Ib0r7M+FPwBu\/il8Sb7RtUmmFhpmlrfTwQNtaWWRtqKSCDjgkgUR44p1MRHDwWrNJ8OOFP2snofQsfxdsLi5AW5U8+o712H\/C0tLhQA3Cj8a\/DH9uufxd+y18VdHsvBst2bHWorgtaTMWET25XLISfusG9eor5+s\/2j\/infopTzQe4J\/+vX0sK9ZmUcpTjz9D+k0\/FXSM4NzH6\/eFVJ\/ipo4JP2mP\/voV\/Otofxj+K+sXIj80rubHzP719E+DtC+PXjmMJogkcN\/GSdo981t7Os9TGpgoR3P2Mn+LGiBebqL\/AL6FcvffGnw9FlXvYR65ccV+QXxA+E\/7TvhlJbi4ZZI1XeSrHivli6074z390yzX5QKu7aGPH60qMK0m0mXHC07H706l8ePDEGWF\/b\/TeK891T9pTwtbg7r+Dj\/aFfkV4L+FfxH8S3ypqGqEhsHaT0z2612HxH\/Zp8R2WlCSLUGDsB36\/rXbTyvENOVyJ06Klys+6Nc\/ay8JwOR\/aEHB7OK86v8A9sfwlAxH9oRHns2f5V+f1l+yfrV8d93euRtLZJ9qPh5+yla6j42GnX10zrtyQTkdq3jk1Z\/aNI0aNmz7f\/4bW8IB9pvl\/Piq9x+2Z4NOSL8Z7DPFeU3P7At34o1P+yvBNnd3074A8hcRqfVn+6Pzrpk\/4I3fG3VmAmksrIY5824LEfUCpq5JWWiuzKnUw9rt2NNv22\/CCO0L3oyO+a0\/Dn7V8fjPWk8PeC0vNVvpyEitLGNpZCT6hc4Hua6b4e\/8EObp9Yiu\/in4mjh05XDTw6cG86QDqoZjgA+uK\/Yb4QfAT4Efsx+Hk0T4SaJaWbgYnvnXzLuZgOrytljWlHIJvWTscmIx+HjpBXPxQ\/a98NfFDRfDVjc+PrV9OuJtN82xtrhVcR+YxDOccEhRnaf61+Nfjnxj428JeFftnwmspLrzL57KXWNvni6vo2VZoLYAFmEIY7pGO1irbVAAr+tT9r3wnpXxr+Gdxpd+hkubUM9rzhisg2yJuxkKRz+HHNfnVoH7F3w88FaLZaJpqSQafZxKzWMPInnfLP74Zzlj3qHgoU695x5o\/cfpfDmZyxGA9nCfJJaXWp+f37Flz+0DB4T8c6z8XPLSOS1tVtIoSfM5kLFpFUbB8o4xknPPSvJbPSbU\/Eb+3LoXEsF3IFSVWMckW\/q\/y44X074r95Ln4faD4b+G2paTpsUERuEDSSswVd7ZwGJ4IGOxr8TfiTLafDXVLy88XalaadaW+64kv2ZPKSLbwxOcbQPfvXxeeYWp7eLgt10P37g2rRqYCcZtb7ux93fDu1Q6eI9PuAUt1C\/K2Qe5Yj3611+rX889rIjIsj7di7zgk4+gzgc9Oa\/OX4T\/ALUcb3NhqXhC+svEmlaiRFbXSYUNs6jdgfqOK+831y28T2RvZybeV4vLCe7DOdw\/n0rhnOpGPLNm0cLClPnSTT2aPn\/xuYtP0+aK537pyqyRknChRwxUHKg9680s2donVgsrgdQTwD0HP+ya9Y1TQ2m1PZqu+SNPk3OfkkI+7k9R61xuv2LWt80e0BJFXIUY3Z4xnjB9OK5FY7cTiIyTSPMtTWaK6SW3PzLL5TDJUBOj5x1yO1Wbi51DUfD2peHIL37G+pwmO1vfLL+U24hW25544qbVrYohToVIAMmTuye\/vjjt0rEm1NPDGiN4gnjnnjtmaURIAZCoOMIDx3z+FbU0neJhCSi6bb6nc\/D\/AETw78Ovij4XvvDlutvBpp\/tPUrgDb5t3903Dj+8w3E+ufav0Lvf2lNF1FWj+1JkksoJA4r8z59Um8U+Hjd6OJ4hdNGswlwsqofmA4J47fjXlet6RrNt4htoYJJghTnn0NfbcN5BOeGdZu12fhnjHnNPEZjCjD3uSO\/m9T9T0\/aL0t7hraS6XIHHNXoP2ktEsZ9s10oz6mvzisvB91N4jeOQyYG3Az7VH8QPhxNaQfaoJZEPXbuJ619DiOHp00nzH49TnGcrWP0hvf2tfBOnuJJr2P6bv\/r1y+oftt+ALZd7XsQHrkc1+HPj7w9q8NoxS4lzk4IJ7V80TaXfzOUnuLjGecua8etDk0cj28Pk6qK5\/RhP+3X4CYHyLyM46kEcVzF3+3N4N5Yagg4z94Yr8NPA3gpZNMu7i4aSTYxK7mJ7VxUPhsTR+bIjdefmPrWLUVqpHbDh5H7j6l+334Mt9xa\/j\/BhXAaj\/wAFC\/BSoSL1SfYivx4l8G6PccTwA5HYmpLT4baCM5t0IB5JJIA9z2\/Gpsusjpjw\/Bbn6han\/wAFF\/D8A\/d3hwO+5eRXKL\/wUh06+kaOwuJJSvLBBnj8BXwvYfDnwuFCmziIIzkjINemfDX4ZaCmqXHk2cIBhJ4X6048q+0dcMiglsfSL\/8ABRq13HJuPf5W\/wAKb\/w8atPW5\/75b\/CvlS+8HQRXs0YgiAWVgBtHGD9Kq\/8ACJQ\/88Yv++B\/hU86\/mNv7Fh\/Iz\/\/1Pxo1S2zZOB\/dr5Y8UwvHqCkYPPcc19fyRLNbvGB\/DXy94ytH+3HB4VsYr+RMmmlNn9uZ9h5SprlOv8AgJiLx\/CjZ6gg\/jX9QHwA+fwnGM5Oxce3FfzB\/BIG38e2rMc7sH9a\/py\/Z4dX8KRr\/wBM1714\/FD1uj47MI6a9j6VjJ244\/CoZslcjp71JGwxxxUVw3PFfLX2PmuVGHO+B0+prJuGJ61r3JBJ+lY0+c1mUZzMROp7BhmvoLwe+dPIH\/PM8fhXzwxxIM8fMK968HSZsyD3jI\/St8E\/faKqrQ+a\/g9KsX7RWrIP4inX6mv06+Gnxptvgn8aJde1CNpbO+0n7NcRqVB+U5BAYgEjJ4JBr8p\/hfdLD+0pqKHjIQ\/qa+yfidY2OseIFsLySKMy2ZEXnkIpcdstxnHrXHPFToZlRqU3Zpo9hYWNbDOnNaWPgP8A4KT\/ALRuk\/tCftMaXa6FbmC00axmjjEhUsWmcMchCVXp6k+uK8MsbYW8UW1SSVACqOST0ArnPjn4M0PwP8abOzsrq0uL6aF5Lm1tHWQwqWAjEmwkB25wp5\/MV+wX7F37Gz+JUtfif8Srci3XbLYWMo6kdGYe9f0Rl\/PXcWtW9zwMXUp4TDrmdrX0PPf2U\/2Ntd8ZCLxl47ja0sC4lhtmGHlHUFvr6V+uGk+CrDw1pkek+HrWO2ijUKCoGTj1OK9nt7C0srdbW1jWOKNQqIo4UDsKk8hWBIXr2Ar62nl3u2Z+b4vNXUnfofPWs+Cm1WN4b5FlVxgjrmvlT4h\/seabr26+8LH7HdNw2funn0r9MI9MJXJAA+lXLbw68\/7xhtHXnvV08ps7xMo5rJbH5FeEP2TfiT4dv0lkeCVVxyvGcV6L4r\/Zn+I\/ia2S3sI4srjJdsV+pNtoEDfutuefvV2NlottBj5Qcd8D\/CvYw+Dmo8rZz1M3blzW1Pyt8F\/sP+NNRmWXxLew2cATa4hBaQ\/QnFfRvgL9hn4PeD9TXWriK5vbo\/ee4kOP++Rx2r7eWKMfcGPpj\/61NeQRqcjtXoU8KlqcVTM6krmFo3h7QfDloLXRbWG1iUYyi4J\/z9abeSpFGWGMg9TV6WVZVO89BwM1594gvvNH2aEkAcZB61U0kmc8bt6s5XxbrtzDbyGybLY714dB4rMl4bLU5Njk\/ePHNdJ4k1qDTz5c8qcnoTzXgfifVlub+OSzUFpW2gt29x+FeTXqu+jPVwtJNGz4xvzp1nf6hdgPC4MEC+u7qw9QK+VNS8fx6vqyaZYeWoAEcjMMbSpyR169OelYfxl+Ouj+HNQls9Uu41iVPJiiZsliBjheuSfSvnbw7eax480i68U6daXdm8Uv7uW5t2jSaHcAG+YevHPXPtXymPxLcvdR+ncFYmGHnyVPtG3+2h43+J+ifCS8u\/g7Z2+r6sHHkWNwXWJlVfmLeXyVXqcdOua\/C\/xv+z\/40\/aZ+G9ofjDpB0q7upp5LnSLa+LqZEJCSo55eNwSyBhlT+Br+kLwHpaXl3bavqoUSJaszSkYVCwIyMjBPbngdq+J\/wBoH4oaP4M1O\/tby1a5jso0kgjjGH8tyx25AK43Do2MZyeMCuWlRco+1nK1tj9WoZw1OGDw0OaUm7+nofk38PPgHqXwis9J0PwvbuItNiL2scfIPJMnBxufJweB7V99eG\/F3jFptMnnWPTYXiFrNFcMGW4kK5UjoVOMc8j2OK+L9a\/aO8Z\/EDWLqx+FGiXF9I+1bq6szvtbY7fuPcyARBs87Eyc9s1xen\/DH9qPxrqqS+IfFU2i2EUySfZbWKKdlZfujMq\/KcdABn9K86vCi5c01959Zi8ozCnRjaqr9ux+mt7q8iPs3QtA2I0fJIZim5gVIyGXByCOMGuZ1K7g1SxkjuH\/AH9my+RKThWXJHJHXvjNVvhXo2raKDovjjUpbuAQyB7qJQBMw+dWdNzEfNxgdDkgCpNb1rR2v2jVsvJC\/wB0D96c53qOSc984Irwq2Gjzc0NjPLcdWvy146nJahNbIvz4CkLJJvzkbRgEdjg964a81i2ttInt9QKqknmbVzuBTacHk8HpnH1rB8beLk06JppdiOj8h85KAgkcHrgkjNeFjxXe+IpJLl2\/wBGVWK4w\/A+UHrj5gcdamjTt77PQxFVTapR3PoD4beJbGXV7bTc8XOIS2AAW9gPQ9zXrvi7Q0TxPZYXrjP518bWN5JputxPgp5DAh1OBkc549x2r7yi1C18V2WkeIIM5lXbIOuJEOG+nrX33B+YL2VSi\/VH434k5Py144iO2zO3h0KOPXi8Y5IUk\/gK5L4o2jCIxkcEV7RHb41jAU5CKSSPavP\/AIleT5ZEhGSM19vmc\/cPyXBU71j4B8caQWtJAR1z+FfJGoaJK12So4z2Ga+8fG0URtnII5B6V9Of8E1\/2R\/B3x08Zax4++MGlnUvCukhdOtrR3kiS71Gb5vvRspZIU5YA4JZR2OPz+rTlUqckep+gLEU8PRdSaPzH+G+nGTRNQDjpu9+wrzb7A4gKgD72K\/o6\/a3\/wCCaelaFY3fjz9mHT\/s8ZieS\/8ACccjSFlUEmWxaRmYtt+9CTyBlOcqf58JbaW3ka0mRo5I3ZJI5AVZWUkFWDcgg8EHp0rDMMLUoyUJndlWPoYmPNR\/4Jy8WjPJiJMl+NgA7ngfrX9tH7OP7PXw\/wDhp8DfDPhC00PSyRoVo2oGe0heW4lmjDytMSmXJJ5zmv5HvgF4Y07xn8aPCPhK+UtFqHiTTrSZB1KPcJuH5A1\/cTp8cccaw2inbFGsajsFQbRz9BXq5HT5udtHyfG2KlF04wdup+Wv7R3\/AASm+BHxpWTXvhesPgXxD5m6SSzhMuk3AJ+YS2ikbG9GjI56jFfn1r3\/AASc\/ad+EN3Pr3hs6X4ysXjwy6HIYrtf+2E+Nw\/3XJ9q\/ptj0vbHvumZgerDj8B\/jU9ppjx4+w5jVTndkj8q9avlVGo7uJ85g+KMVRXKpXXmfxZav+yt+0zb6pcQy\/DzxfuWZgcaZcMOvqFIP4Vnf8MuftK\/9E88Yf8Agquf\/iK\/t7YXrHLXL\/rSbLv\/AJ+X\/Wub+waXc9hcfVf+fS+8\/9X8hrfJiIHBxzXz54vgVbxic43E19EWKK8RIPGPSvDPHEPkXJkbuxwK\/jXATtM\/vTGRvCxV+E7AfEGzwPTn8R65r+m79nHc3hRM\/wBxRX8ynwtOPiBZEe386\/pt\/Zw48Kx8fwKT+VcXEz0TPz3No3bPpRTjNQSvxmrLg+nvVKUHPH418opo+YlAypn61k3ByOK15kOMDrWVcYA96HNIap9zEkbEg\/3hXuPg6fba4P8AcP8AKvALgy+aPTdXt\/g0ObXHbb1q8JVSmrsKu1z5O8BXDQ\/tPXqr3VD+bGvon9qK6EemBiSD9nPP0HY9q+W\/D9z9l\/agn38ZiU8f7xr7s8S\/CnVPjr4\/0jwRp6k28hSS\/deiwKQWH\/Aq4sbhalfMKNKkrttHv0a8KVB1JvRK7Pjr\/gnJ+w5qvxf+Jtz8cPHcUg0K2uP9AilHNw6n75J\/h44HtX9QGk6Jb6bZR2FjGIYY0CJGgwAB04qp8Pfh3oHw38JWfhHw9DHBb2kKxBY1ABK8dq7lAy9B06Cv7IyDJVhqEIy+KyufhWe5xLFVW09EYr2FqRgAA9MGrVtpStyMe1aohIPmMBnPJpw5PynA9K95UUeC5MYunxQDB5qWOzdvnkPHYVKigvg81eDJjIz6YFaqCMnUYyCFU5TgVZyenv0qvkAZNN8xQM81cVclssu+0YrPubgxqVJGPzpJLiPvz9a5m\/vSWI7DmnzPYcY3GahqW1SqMAOhFec61qaJbsVxnBqxrmqShGWMDpyTxXl2qaj5g8uRuSO3rXJVn0OynE+cPiDezzanI08rIuegPavN\/DTeJ\/iDrDeC\/AdlLcXAH+l6nID9ms0buWPVyOi169q3gHW\/iF4sh0LRSczOPPlH3Y4h95j+HSvvLwr4I8P\/AA90CDQfD0EccaAeY4A3Sv3dz3J968mnhJVJtvY9WrilTilHc+NPAP7FPwm8I62PGHiW2Gv69gbr\/Uf3qRE9oYidiY+ma+kdV+H2g6npkum3VtD9nliMLxqoAKsMELjGOOn516m1hhvMdcnnDdzWRNBMCW+ox1\/OumWApraJxLHVOa\/MfkLr+mWPgS+8SeGb65dotMt54oGA+dzEQ8XHHqM8469q\/Cfw5oM\/7RXxT8TzeLnvG8HeG53W7srORojquoyfOYGYYfyUjCmT5uSQMkV\/Vt+0X8HLjxnoieKPDcCTatYJIksChVN3aSf6xD0yyj5lzyeR3r8P\/BfhFNH1DXNA0jSkjS\/1ea4DhPvsygN06kkfNxwSQelfNY2hOnHkUdLn7Xwhn6lN4mE0p2tr0PkZPEd\/FoyaZ4VtdO8O6TaZNvpNsEjfYPlGzCgk4wcKBkda7rw54Z1bVNMGrBnLCMzSyhTyM5DAdh+H1r6MX4V+F\/D0scmrwIb+7lITzUG2OOMfP7Be2K6ab\/hD\/B99qsxlUiyUf6NGG8sRzxYIbsUUEYVe+O9eNi8q9qrrQ+\/w\/FFRN1K0+a+x4bpvhhdNuVvNZnuraSTe8axruyVxkbfxHbketfN\/jPxdofhzWNSSFvPRtksAWMggSj+L+6wIIbAxn8K9T8VfE\/UvEWm21ybiB7W4XzHkZdt1EImZEIOCcEDoRngV8N\/EPWJo\/NIjjWOZjvmQ\/Mx+Y78E4PJJxjvXNPLoRp66HJTzivWxF46nm\/jvW9S8X6s4t0ZLZSRPJnBk7HG4HsMc59MHpVnT1\/sxUtLmI7CUaMRDJREyeR0PQYqhp0ayNbWkjsFQ77rj+Fs4Unrk8H8K+hvgb+zv8Xf2mfEtzovwc02S6hRxBPqMgEVhZID8zS3D4XOMfIpLnsK8j2cq0lToxufp+CWHwlB4jFTUV1b\/AEPMZCski3OJJJpOERVO+RnxtQAZJJPoK\/Zz\/gn7+xL8VvFumXWv\/HrSZvD3h15I7vSINQLR30+eWKwAqyIy4+ZyOegNfen7Jv8AwT4+Dv7M0EHizXvL8T+LwAzavex5t7R8HK2ULA7cZ\/1jZb0xX3PqutBI\/Mkbv82e9foOQcIypNVa0nfsfzZx94m0ca3QwcbxT+Lv6I\/P7xl+x7Zz+Kr7WPCmu6Tpukq4EVrqs22WL5cldzY3D0P514bqH7HelfETWF8P+HviL4Nmv3fYLSC7SaUn+6EVsk+2K+Mf+C+3gzTPiF+zhDqVj4ih8PeJNF1RLnQvMuWh\/tGOXEdzbFEOZNq4dSVwCOoJr+Tnwr4t1T4UNYXfhTVLw6tZ3K6iutJI0dwLiI7omQqcrhwMLnpnPWv0fD8PPE025Pb8T8ihm9Sk1yn9u3i7\/gkl4q+x+Zq\/jjSLWNz\/AA20kjlc8lRkZ498Gvtr9nv4U+FPg14Es\/hH4Olmez04ySJd3AAmuZpX3yzSKvALHoATtAA6Cvin9nr9vu3\/AGlv2etA+Lup3qNqskEela1YxA\/6PqNqoW5BXHCsfnT+8rAjvX1x8OfiLBqCreNkh8EdMgEdfX86+Zw+WKnWa5dUeri8zq1qNpPQ+p7qe8szGtyQWG3BB5xz3B9RX5iftZ\/8E3PC3x98UR\/En4ZX9h4b169nzrKXMbfYbxj\/AMtzsyY5v7xAw3UjPJ\/RW0urfW5lDzbUcFc55ypzj+dL4lv7DTFWKKQYI9Cc\/pTzbBRqRbktSMpzGrQnzUp2Px1+Dv8AwST+PfwZ+OHhb4p+IdW8N3ejaHrNvqd0LOaQzskTZXy1ZBkk471\/QnoQBgEr9X+bjnj+lfMOi\/Fy9kaLwXdsZoLudFtnb70eDkrn04719T6AgMHmEAqVwPb6VyZdg6cOZU0aZ1mdevJOs9jpY4BKA5O4duetdDbWQlQD7o6EfWsqwTzv3knC\/wB0V1UUgc7FAHPOK9eNLXU8KVV2D7AV+XI44o+xH1FD3gjYxnHHGSP\/AK1N+3r6L+X\/ANat+WBjeR\/\/1vySTOgXT2Gr\/upU42njNeR+NVg1FysGSNxwQc1\/f38Rf+CdX7JnxIj3+KfDdlLIVxuEa5\/MAGvmTWP+CKH7GWr2jw2OgtCzn5ZEd1I+hDZr+faHh3Upzcue5\/RWJ8WlUgoqDR\/EN4Hto9G8X2mpXAKoh5J\/ma\/dX4MftI+EvDnhtYLieFcIv3iB0+tfZ3xX\/wCDe7wdfzm4+Gvie70hc\/NBJiZcfSTJH515dpH\/AAbwatJaSS698Qr88ERJbJHGB6etGP4DWIWp89V42c05NHLy\/tieDg2BcW49yy8VRk\/bC8HE83MBPXAYV+eP7TP\/AASt+P8A+z54nWx0OTUPE1lM5WCe2BWUc8B1ztP14r5V8YfspftH+ANM\/trxN4X8QW1p1MyRtMB\/vCPcQPwryaXhvh2n72xwz4nn2P2pl\/a98Jfe+0Q8c9RWDd\/tg+DkUhp4D+Ir8evBn7K\/7SPj+yF74Y8KeIrqEj5ZWhaEH6eYVzV\/Vv2N\/wBozS0eTWfCPiKJY873SIvjHX7pNZVfDyhFGlPiGct2fqm\/7YvgvzMCaHr0yM19GfDr9rTwTfw4MsR+TGAwr+bq9+Fl1psxg1eDVraYHDLcRSoR7c4ra0nQ7\/w84nsdRvbYE4yzMFP\/AH1XA+BaS1TOpZ3N6M\/cTwj8RNC8V\/tIy3mnsMeQoGDwTuP9TX9QP7M3w1tvDPhmHxZep\/xML2EMXYfMqMOB0r+P3\/glV8F\/Evxx\/aoguI7ia503R4hcanKRldxPyRn37mv7kdKtEsLCKxg+VIkCIMdlGK+t4O4HhTxn1+qr8qtH\/M8jP+I5Twyw0fma205yef8AGrATC7j3HUVGoBHzc0u7I4OPpX7B0PgPaMar7mxyRSBsOODjNPVAAOcHHUU0ErkZzQlcbmWiw7cfSmCb0OKgZxGOD9aj80HNVymZbyW5bn3qMyLgqTj61W807SwOAOoqhJckZ5zzWiVgGXkyq2Aw5rl9Qn4+UEk1rTyb\/vY65FcrqsojjL\/xDispPU2hscLrtzIAc8Adc15BqN0BOSD14Re\/t+ddx4ovpHtZTEcvtOFrwjwrc6hrPj\/TPD94DmS8U5\/2QcmvLqy1SPTowsrn3j8N\/Clt4c0JLydB9quk3zP3APQfgK7eQwynfJ06D8KnmdY08kDCj5Rj2rPm8tSMY+XnPJr1ORJKx5c6jcmyrNIqrnkDPT6VQ5wWB49PrUk+w8HuTgnpVMShHGzBqeW+g1K47DW6gL8zN0J7Zr5v8c\/s82l\/rT+MfAMVnbX9wGS+tZxtgmLHJlUj7kvqcbW7819FG7WSTORxxg\/41a+1xxjgjHc96znQT1aOiGLlT1i7H4T\/ALSGg+J5LjXtF0Jrb+1LISWrwsB58QdVO\/DbcjGWDpwRxX5deJvirL4Ua\/srmZb3VGSK2ijQNIo2srCSQsMKcjkc+9fuz\/wUPi0DwBa6L8ZdZll021upm0LVNXgTMVq2CbeSaRfuAklAx4yea\/BD9rOyn0bwRb\/FPSVhSO9M1u8yHiW4jOBIAOAHGGGO+a+bzCvClUtKNrn7Lw9ha2Mw8JQndfivI8p1nWNS+yx6nrvk+c0Yi8u2yqRICSG2jPJzyf8A61fNeuXeseLNUi0vw7BPd3l5OLbT7K2Rp5p5W4AVFBY46sRkADmvqn9i79kn9ob9pktc+G0nOjzoUvPEOqowsbYtwREDgzSDJ+VOh+8RX9GX7KH\/AAT2+DP7KGmC98PQTat4imjK3\/ibVsS3cmeWWEfdgj9EjUdskkZrkw2R4nHy5krR7s97GcTYHIotOXPV7f5n5Wfshf8ABJfxHrtja+Jv2oJpLCwk2XDeHbKTF7cFuSLqdf8AUpjGUjOSOrDpX9APg3wp4N+GXha08F+AtOs9K0uyiWK1sbGMRxIoGBwPvH1Y8mupex2ZOSOM\/wD16xJ3ihJOdzDk199lnD+HwsbUofNn4rxNxrjs0qc2IqPl6JaJFy4u1G6Vz0G7B7CvgP8Abh\/bl+GX7H3w4l8Y+MpI7nVblGj0Hw\/HIFur6foDtPKwqfvSEY7DJqH9uX9uHwL+xz8LZfGXilorvVrvfbaBoKPiW9uQMgsf4IU6yP0xwMsRX8JH7SH7RvxA\/aM+J198T\/iVqE1\/qF5IzlFYmG3iyRFbwIxwkSDoBn1OTk19VgModX35bfmfHyxFtLkv7UP7VvxU\/aj+Jd148+JWom9u7gmG2tYsx21nAvPlwRdEUDjOMnqTXzppGjzSXC6jqDuSSsnlgE57IvpjnPPerENhpULGdZN28Y2sR91eW6E4ya7W2tZLG0fWtUMWnWigE3d0HVS7Dog+85xwFVSTxgV9jRwqjGyVkckql9mfW37GHx48Q\/s\/fFC2sXuHPhjX7mKw1mB84Uru2Xag9GhdgGOeUyD0Ff1c\/Cr+2p7Y2djdKsgHG0lxgYIIIPIPBB7jpX8REel+LPHV8IkhksfD6x+Whuw0d3ecY3FFw0cfQ7Dgnviv1W\/Zl\/bo+L37Nuhx+HLl7TxDpNrIohstQEiTW6Y+ZILnzCwUHkK+5R2Ar57M8pdR89Jano0MbpyyP66\/B2leP7FDqN1f2zwxL5piIy3y\/Nwc9T\/I1teJdRkuYXuonMgUEhsFQCOuMjmvzB\/Zl\/4KQ\/CT4yXttoV9ejQ9VlxH\/ZerSqqSE8DyLj5Y3ywwAxVj0x3P3trWu6xqcQs2jIjiQh2UdcHA5\/Wvi8dhJq8ZxPSw9VXuiL4f6lcT\/EnSYX+dVkll2jPBC8H2\/Gv050e8UWqAZGcYxzmvyF8G6gmnfF\/SN7kM3nAljkn5e3Hav1F8P61F5aFz1A2kepryKNLlcjXGz5pI9zs7pUVUUZ3cVvJMYx5UIO5uB7HuTXDabdKFNx0IHy88V1WmXDR4l6u2CSfbjiuyKPPc9TY\/suBvmmYsx+8fU0f2Tae9XAjEZO3J9hS+W3+z+Qo5ETzs\/9f+xSe2iEYmBJ2deakGprDFsTGcZXNPjhf7IyHnn8T9ahvbaJUQdG6Yr4yUmtT6CEVe5yOsXM837yLuecf\/AFqm0aSaRPLuBtGMe1abWsKRNEQODuUCoZ2SGMGLjcO\/FcjbT52zqWqseXePfC1pc3aXkMccrJycoDz9DUmnaD4e8Rab\/Z3iGxtbmLHKSICBXWXzrJb+WTyc7\/8A61crp80lncuFyAM8GvKlJU6vMtmdyipQSfQcmiaV4Vj8nQrK0hgAHyRxKMD8qmt9J0TXo2W5tbV93VWiU5\/StyQpdwEf3u3tXNWpk0q7JGcE1tUxLve2hKpJrlR5F4x\/Z1+Fep3ButQ0HT5Gzkkwrz+ledeN\/wBjT9nf4leDLjw3rvhzT40lhaISLEuVyOo44+or7Yup7a908tLjIHWvMobiXUNfi0C3+bLAvj0rJxXOkuo+ZuL8j5u\/4J6fsB\/D79inQNctfB8s1y2tapJfGe5O90RgAI1YjO1QMAV+lqoy9sjHbpVKxtltoFgjXAUAVZkkCcIfwr63DUVTgoo+frS55XJ1kC5DDFPyNnA\/KsiSVsfvKh+1tuKKxGOta3I9ma7PzgcfWk80gfMRj6VmNdhhgjPvT0mcn5cfStFMnkZYmlz1GRUasSPlxg+lV5526Nxz+FRpK+0BSAetWncktyZ2lcGsmd8nGffFaJdsbnJP0xWVdLgjPehgVpJj98EDAxiuS1i\/URNGApyM+\/1rVu7jYdpGfpXJ6innctkDGa55bHTTSueUa0lyJmkDHZ15q18KtAt9R+I0WshRmxhdwcZwz8CrOutGseD0H+RXpHwe06Gz0OfWSMvdTldx\/uJwMVx04c0zqnU5YHtE8oYjLEd6pzzgIQeSeN1UXvOS2Pp3rEvL9UJOcemB3r1Xors80vtdBGJY7ueMVnXM32cPKpBHOOeleL\/Fb41fDD4JeFp\/G3xa13T9B0yIZ+0X0oQufSNPvyN2AUEmv59\/2s\/+C\/emaIZvC37K2gG9mmf7PB4g8RRskZdhgeRZhlY8cgzMo9RXXgsqr4h2pRMquIhDqf0daz4y8NeFNNfXfFWoWel2keWkudQuEt4hgZPzSEA4HPWvya\/aM\/4Li\/sXfAyCa38PXupeOL6AsEh8OW5+ys6nG03k22Lr\/cD+wNfx9ftPftf\/ABj+PHiGG1+K3ifUvEt3C2+RJpAbaG4kALRW1tE6xRqnT5V5BAzkmvn86JeaRZ\/8Jh49nbzJG2WemlxyxBILsRu2r1Pc7j3r7PAcGw19pK\/oeficwk9Vof13fFL\/AIK3eIfHv7AGmfHzxn8PdPh0DxZ4puLS68KXh+2S3Hh6F1t3kfzlUea7byF2YAXAGea+lPgt\/wAE6f2L\/wBo74C+G\/iL4FuvE1p4S8QJDq6aHJfm+s2tCpkeOyaYmWzD\/cZAxKDKgDAr8Sfh5fw\/tOf8EfdC07SOLvwz4m1DSJJSNq+bb3AuNmTkYaObg+q1e+HfxK+M\/wAA\/hBY\/BvwF4v1HTdE06WWSC1S6eNYp5yZJQsgZNi5Jwgbao6Dmvu8L4aYPMsJSlBRUovVvt0PBn4gY\/Kq840puzWyZ\/YZ8NLXwvo3gCw8O+EbCHSrDRwdLtbG2H7uFLfhFUtgsCmCSepz1q7reqxwsGfGSOFXrz0HrX84X\/BNP9sPVPDn7TKfB74jeJZ9Th8bWhtbFry4MqQalagyxBGZ22mVDIp46hR1Nf0T3Fi95d7YwVD4YuRzj9fevm+KeH55VXWHlqrXR0ZLnP8AaFH6xre7vd9Tlb7XHf8AcsOuenNfH37Wv7UHws\/ZG+Fc\/wAVfihcSKrsYdI01H23GpXu0lLWH0LYyzEhVXJOK93\/AGl\/j98HP2Qfhhf\/ABe+MV9FZWNqPLtLYYNzfXboWjtrdP4pHI6\/dUcsQBX8DP7bv7Z\/xa\/bd+ME\/jjxe72thDvtdA8PW5YwadZMxOwx5ZZpGHMkowzN6AKo4Mryp1nzTWh6MsQ1ojy\/9rz9rP4kftY\/FzU\/if44k8l3YwabpsW5otMs92YrZVHDrnO6QDLnJ4zx8\/6dpttDDF5\/nvJMA0UdsFk81znCoRnA77eMetd3ZfDXxE+if8JItkZLKK4EBvyxFvHIRkJ5o5izjo4x26cVy1hqd9qerzWPwxWJrgHydU8TSoot7fH3oIVX5J5PoB23HtX0sIU72j6Dr0akLe1i1dX1PPptR8fS+Jx4M8KeH5tMuWhEk+pa1HhLeBj95I+S7Htnqfbp7\/4a8Hx6b5c2oSz6vf7whvb4l5Ax4xFGMJEMn+EexJpuk6Fp3huOSO0M0kkvz3V5Oxlup2APMrnHA7KMKvYYrQl1yOxj\/wBGZQ7cAr8zIAcnJGSCAMnj261vHCct+bU5XUOz+wyC4FvMjW8avtCyMVWNuByQMnjtj6Vky3MVqWhhAOWwFHrz24zXHT6lc3MpaWQuxIGSeBtxn5gDg+uRxwOtXRttbc3cuAuRjODlmwOPvLznt1+vNX9XB1vM6hdSv2QNa2r7lOTk5y2TyAcY9uenavvz9nH\/AIKN\/tC\/s\/wW+hax5\/ifwzGyxy6RqrM8sESgBvstxy8ZUHIU7k7Y71+d1nB4guCsiJ5KbSQ9y2wEA9stuPJ4x3611s9mbdFln1MeYM5FurfLtwPvNtyee3HrXDistVROM0bUcY4vRn9Q3wm\/ai+GHxvnsfiL8Nr0TNaq6alpk\/7u7sZHAG2VP4h6MvynrX61fC74iWeuWsDbk3AAMqndk4r+DDwd8R9b+Hviq38WeC7+a31CAgC5ZAqyKG+aKUKSskbYGQc8ehr+iH9kn9r6L4s+Gje2CR2mqae8aanp6P8AJH282M5+aNu3PHQ+lfl3EOQVcHL21NXh+R9FhMTCsuRvU\/pj0fUw1uik8ud3GfTivT9MdmwxxjPI6Yr4R+EvxZtvENjbpLKDKRyB6ZxX2Vol8k6KyHg4Jrx6c1NXRFSk4OzPV0mYIAOwxzn\/ABp3nP8A5z\/jXPCWMjPH40vmR+1acjIP\/9D+y75dzMTgA81jTXTvzkYUnGfeq+pXuBwSAT0HasGO+kikCk5J6A18FVrrY+mp0dNSe9uwqlH4JPbrXMX9xLC6BCTk9K0LuUBGuX5Zj0PasS+mIbL4zjj6159WbOylEbczm4RQvDA9ayb+CWCQk85AJNTeZkg5x3qaeYNCfM59zXE4t69jpho7CWV0DKBnouMe9SagyyY3Y3YySK5h3aBzcQnAqaG\/EsZaQ5ONtR7V2sy+XXQi1DWzZWbnIAVc4NWfghZzard3fi24Bwz+VCfYda8K+JevT2tr9jtziSZxFH9WOK+vvhjpI0TwhZWJGGWFXcDu7cmunKYupiNdomePtCl5s9Mdiq5FUHds5OKueYMYYEk9KpTMu7njNfaHzaepUeSRnKCqjjYMcjB\/KrrPtz2+tZ80jKA2d2444pNaFBFMxzjBpWnkXgioY1bO8kD+dMdEzjd1pgK9224Dk\/Qf\/XqTeWGSOnWojEAR2\/WopHOflY5ovYmyZP5nlncpNVruaRzkYzVWUuy8scjrimM64ILHPar9oxOBkTrM6ZORkkZFYksM\/wAzEnHTmtLVdWtbFN0jlSBkLXmWqePbZWZFcEDsKwnVs9TaNPQd4jtIxbtJIwAxzz0r2HwJC9n4Ms0YLjyPMz65JPNfJ+peJ7jVnFvArYkkWLPpuOK+vVaHSdBjikKQxW1sPNeQhURYxlmYk4AGCTnGKrDrmbaJxDskmQz3QLNuHJGAo5\/Kvx9\/4KNf8FUvh5+xvpz\/AA\/8GLaeIPHs8ZZdPMga10wN92S7IOS56rEPmPfGa\/PL\/gob\/wAFmfE0V9rvw9\/ZSv4rDRdHkNjfeNYlWWXUJz8si2O5XVIkbKiUDLMDggYr+UrUPHviP4m+KrrVtavJrua8ne4ubu7m3STytyzmRso7E9c4x0HQmvv8p4Yfu1cQtHsjw62MUk1E+ofj3+1l8Y\/2ivF1x44+J+r3usai7MIvPZvKtl5bZBACvlICDwgPTkk18zR6hJpFhJ40vSZbxma00aNTnLncJJdwwzKuThWzgjkkkVvR6NHeSro0bkRKvm3ExwoiiUjOMlly2doCkHngV1fhnwjHrl63i7xG5TT7EeXp8Dg5EaHKAHuWwPmycsc56V9zCio+5BWOBu71K3w\/8G2vhnSn8c+LpiZFLNF5rHJZ8kZBbkljknHHXoBXpH7Hv7PHjT\/gpN+1bafBXwtLJZ6Law\/b\/EeqwgmOx0qFgJNvYTTk7Vz357Vj\/DD4NfFn9uv40\/8ACr\/hdbXI0fSClvqd5aISpnkJxBGcY8yQfKvPyjLngV\/ZV+zN+yX8Jv8AgkH+yfearaWMF14l1O0Oo+INRi3O99fDiCyhc5YwQsQMj75yxzxjirYhyqRwuF+J6GsoxjB1ami3KH7R\/g\/4C\/si\/svWP7P3gWztdPs0ktNP8OaPAAZZZACJZWXgszAszu33mNfzTfE\/4yz3vii90rQLgQpaPscMFWYYPVg47ewx719X+PPFPxc+L\/xD1D9pX45X8gNvDNb+FtEztVJ7hfL88xj7qRKSIw3Vjn3rhP2IPg14V+N37WGn23xF0211Sx0yyvL6VbjcCyquyJZCMblDuCFJ25HtX7bk2GjlWClOcrtK7\/yPyrMajx1dJK13ZDf2I\/2ZPi9+0n8aNN8daJJLpmieGryLWbnxNNEYY43tGEyCJwFztK7jheg561\/XV8Yf2vfgz8CP2fU\/aQ+JN99i0oWoMETcXN5e4O20hT\/no7rgdlHzMQM15v4y8U\/BD9kL9mibWvGzWeieHrZVSdI0A89R8\/kRqoy8krAIAPUk8A1\/E9+3D+218TP2yficdY1R\/wCzvDOnySR+F\/DcMoFnYwOfmKSJ+7lmfGZGkGT0GAAK\/Ic5zKec1\/bTVox2\/wAj7\/KcshgafKt3uZ\/7df7c3xY\/bx+MM3jnxnmy061DWvhrw7BJ+706zZs4HOyeRxzK\/UngfKAK+efhn8LLvxtrUWgW13plnLMHkEuq3cdlaKw5ALzmMxu5IVQrH5uK5PVtQ8JfDfwvJ4n8cTx29uhDJEQvmSu3I2R7ipJx1TFcf4Ctdc+K2uw+MvHUNxZ6HaD7bonhvZxIFbMVxd5HIY4Kx8g9+K6lyxtTgte3b1OtS97nlsanjnT5vEF7P4a0251XTfDtjPNp+s\/bP3WoX15bOUmghKsy\/Z1YHEpJOOAa2tBks9P0tdO0e3jtLO3TZBBEPljHsBncc9ScnNc94m1W71TXmgjcssbbEIJbgeijaw69iQBz6VkeJteW3tvsFiApUckAcMBklgQCAo5PPWs8LR9knzu77nZmGLdafMlby6G1c6ykUnmEiQ7uflBA2kFsgbW4\/U\/Sqtolzql4SgO3cCvV1U8YAYfMCM85z830rn9Aspr1Y7uQYIYEl8kKv8IDjkYzyD\/Ea9Rs0hiuBY6eA0qqJHk42pHnCneCOSeRnk12UqTl7zPOnUsS29nJEzx2UZnmjAdTwQMk4DOuCBnB5+vcVdlvLTRyDIy3F1A7OZuNoKgA7Awxjdgc9hjiqmo6tBpFu1latISfmlmKZaVk+UFirc5fp7AVw1zf8kO+8JnJVjk7OWOGznMhHftWs2loRG71Z2jeI5GYyTbl+bknPAQbm+YE\/wARAz+dRz6nllK8dAzZ4wPmb5l9TgciuGW4EGI5HAlHVT8jYT5nH905bA\/Cr6XM3mlgOVyDn5CxX5mAI4OSQOlZK71K0Os+0xu+1fvMuGA45xyP7p5I9DXdfC74leMPhX4mi8ceDLpo7m3P76LcTHPETzDIOpUqO+ccEV5VZQyNlSrKz8D+HJ7\/ACn5Sdx7Y6VuIBaxNIoOSDHg8Y4xjnJHC+uDWVekqsXCa0e5pCo4u8Hqf10\/srfGZPHWl6N4w0GY+RqVrBKsSkDYzY3D6g5zmv3q8Caq8umRNIwLbV3HPOa\/h4\/4JQ\/GrUdL8a3fwm1eZmgtyuq6Yo6xJI+JlHqA5B59e1f2afCzWnuLKIs2VaNSCeK\/Bswy14XF1Ka2ex9jHExrUlLqfVsQmkjEg78\/55qTy5\/8\/wD66xbe6CwIN5+6Oh4\/lU32xf77fn\/9an7NHJd9j\/\/R\/ryu5CZNvXJ+b2x0rnprjZKUAzz8x9KuT3RiJMvzHpk+tZjOHBSPqRuPfIr8vqVD7KEAkv1aMr7Y59qw53ZhvYMWyMD2NWzFlTgcDuff2rH1JPMtJraSaSAyxtGs0Qy0ZYYDgdyvUCufmu7S0Nox6oXkupJ471YklzbkY74Ar5L8BfHSLRfiOf2dvjBeR2Pixo3utCuZiI7fxBYr\/wAtbVjgGaMcSxZ3A8819QW93DLci1WROCAQWBwe4wOf8\/hWuJw86LSns9mbU3zbIoyXGyTyJOmc9Kwb+6Fn+8Xp0PpmvY7XwjoF9Mp1GeRnblI0OxWx6N61c8TfDbSNd0h7XSM2k6ghH3FlLf7WTzn14rmqYWck2io1orRnxE4Xxl8UNM0SMbo4ZftU2OQAnTNfo1o6BbVUXgAd6+LPhX8N\/E\/hHxzqepeLbdopMiK1kHzJIn95T796+y9NdvIA9a9Lh+k4pyktWzjzepeyjsbm\/wAvjPWqrNuJbOathF2Y6+tU5FMY49a+qseAviKrSbhg9\/0qtNgYz29qlYkMPWqtw6tzn69sUFlSa7JY5yPTFNFwMfNyKyJpEaU7SeKd9oKY7gip5lewGsZz1XIz2qrJI7NgUBwyAiq8u8jhePX\/ADitIx6mLi0RSNIGKjIHXJrMuLmQ\/u4ly36VNcyRRRb7uQIBzj2ryD4gfHDwB8NtJl1jxHqFpZ28C7pJbqVY1A9yxGKUpRvubQi30NXX9EubyUS3EjEeimuTudDsrONpUQZ7kjNfLXwD\/wCCh\/wM\/aM+LeofCDwdqUVxeWsHn29wgKwXBz8yRM2N5XuRX2frFoY42GOvBUj\/ADmuerTOlJq3MjgvAuhtrvjaMFf3EDee64z93pj6mvw2\/wCC2v8AwUVu4NUf9hz4EanJHf3i+Z4\/1nT5drWlpt3fYBLGco7jmT2IXvX6xftN\/tA2f7Hn7KPjf9oFip1C2tDY6DFJlhLqEw8u3UBQWIDkMeOgNfwU2niHxV4itdZ+MGtXNxqGv+J9RnmN3MZHkcF2MkqPsZxukyTkdcAcYr7zgXI\/bfv57Jnzue4yz9nE8i+Luvi6mi8MaBiKCFliUIThiAOBMhOSOmGxzn1Jq5oOlad4J0L7dfFftEoTCR\/e3HhdwgdvvE8HZT5o9H8FytqWsZl1E\/vgjKDLyPvYRoXOF7lSR1p3h+w1q71tfFOrATXuDJYWEhEjRK68TMXAdcj7it9eBX6bU5efmaPHp3ceVHoPhzwo0u2C6wklwftOpqGBOF5WIlQBlc8nAOevQY9++Bv7Nnxc\/bj+K8fwP+D2zTNG0yNb7xV4omRjZaRZkkRl1GPMlkP+qiU5cqM4XJrlPAHw1+I\/xe8eaJ+z78HrGXVfGPi65Nna28bEpFDjfc3M8rKVijiTLSOSMLkfe4r+0L9l79kn4VfsQfAm3+Angtl1G\/uJf7S8ZeItnlzatq0iBJJe5WGJf3cEfREA6kknwM8zVUY+zhuz0MFhXJpyNz9gz9j74Lfsp\/D3TvBHwd0xrdXlKx6jegNqF87gC41G5fqZbg8KBgJGMKADXgf\/AAUL\/aEs\/iD8R7b4d+GbhDo3hmNrGJo+RPeLkTygdwD8iYJ6EivoD4z\/AB2tPhn4QubDw3I66td2jRRTsAptoypG5QOjMAVTGOee2a\/GLUb2fWb2S7eQkuxdtoJ+UjdnkDlR+Zz3zX2PhnkEkv7QxC\/w3\/M+N44zhTf1Wk\/Wx4b8Ti0lrN87LhcMdu7p1AGMd8fWvYv+CfOkeDvhLaeMv2jPilqFvomgaOkVnNqk27EQyXZAo5eSQkKqAZLY6AV5x8Rp7DS9HuNZ1m4jtrS0i865muPlRVUcZxyCOuBk+nNfl\/8AGb46698atH0n4beDvO0vwfo08lxDDEzqNSvZW\/eX008RZSW6RpInyLxyc19nxvVVTBvDqWs3r6HlcLYZquqkldJHrH\/BQb9vLxz+3D8SI7uOO50rwdooNt4W0NZTiNFyPtDzxAo08p5bevA+UdK\/N7x98T\/BnwAsfN1RftniO42i10RQFm3DAU3CoTHsbJ7Bj7Vh+K\/idfnUZvAPwHhh1LWl\/d6lrbKn2Sw3DDKXVVSWX0wDjH5Z\/hj4P+FPh0k\/i7xhL\/wkPiKbLSX98Wk2ylguFBVwCHJGc9BzX5U6ijD2dBfP+up+gcnM7yPJtE8CeLPHtwfi98fXY+XiTQ\/DRISIM5AiLRlhtjDEfL1bBzxX0\/4Umll8Oap4ru1DNfzG3sGaMHdDGApwA5+UFFyQOMHFeJeKvFt34z1aHR9HDzTXU5itlDRuCS3lIw3gYGDJITkLg5z6ew\/E650zQfC1j4csyRb6faC1kVViZcpjzD5kONrOxCjJPJNGCahFy38+5FWPM1Gx5I+rp9rkukVWj+9EXG5MtkoCD8yFyMnPRQBXMWUd14l1kQguU7sWG8pnqrH7wduTyeBXOw3NxePI8pIaRmDMvLKCPmyuBkAHYCBxzXuGhWVr4T0EalLt8yRAwTAliBbpgD5lAH06Vth4uprcdb3Tq4kTShFYaeha4l+UIg8puOrMpyp78\/jWzNKPD9vJb2mZriY+dPKqxnfIPkUYyfl3Hj2rP8Ovf2lhL4h1OGZLq83G2hYI4gt0HyYDHgsSGOPzqpdgLJulK5XkFoSB+7ARcFefvMffIr3lHS6PMvrqcxf3LSzEhRuVgV8xWjbbFwPmHBy5ziqdtYXDSB5h5kSYPzDzFIQ9dy8\/M5NdRItmBstniJQHlZCg+Q7Ixhsjl+fTrWta6fH5xjjjd2Q4TASTJQhFGQQeXP5d64pxdzeM9Dm7PSSZHWU+YeoG5XU7Tn7r4PzOR+HrXfWejxWlpi4X7gJY8oPk5brleWOMZ7UkSCxbaT8o+aNJBt+WP5VwJAeS+Seas3l+ERbaIEFOCFO1jt5JAPynLHt+VPpYT11HEbmWFVVCflC4AyVGWGPutzj39qW+ghitJNo4GFUc4yO2DyPoar2WZWE6thR1cfdJzyXX+HJ7jHAzUmt3tvbaeTI3yqMkN1z2BJx\/L86U17juVTV9T039iDxfJ4a\/bK8NxRsQt1DeafIucBi0XmL68hl\/Cv74fgfqRudIswxOPJTjrg45ya\/z0\/2N44db\/bP8C2fmrGRqM91IS3zbI4HJABOeenSv9Af9nyS8vtNgjt4XISJcBRjp+FflPGLTxcWux9Bln8Nn21G6bBgjp6U\/evqPyqtFpuuGMFbZ8EZHH\/16f\/Zmu\/8APs\/5f\/Xr5w6faH\/\/0v62LxUbCv0PP41hz3NraTBpW+XZjitDWHaFXkU\/jXlmtLd3gxASNowMV+VYl8ux9xQhfU6q41+xLBFfAHrxVKS6t7og5GB39TXkt3Z6suU6+pNNsTrNrumjPmAHBB6GvPWJb0kd6w6S3OB\/ao\/Zs8E\/tPfD7\/hF\/EJmtNR06b+0fDuu2R8u\/wBK1CMZjubaUYKsDjcv3XHDDvXx18C\/2iviL4W8f2\/7M\/7WKwaX46SIr4d8UQ\/JpXi60i4EsZPyxXigDzYiQSeRX6XWOthjtuAYTjkE968T+PfwA+G37Q3hJ\/CXxDtBcQMwntbmI+VdWd0vMdzbTLh4pUOCGU\/X0r2cPOFWPs6uq\/L0I9s4WTW34H0X4a8UgH+ytYUh16o3DD0I7j1Br09PFM2lRLNqJeazC5F5GN0kI7CVf4k\/2h+PrX4p6R8XPF37Kslt4B\/ae1Se7gW8js\/D3j+cH7Lf2zHbFHqDDi2u04VicJJ94HJNfq58OPFA1izjukcMrqGV8gqwI6gjgjB+leY5Tw9X2D+TKq0Yyh7Xc+gV1exvoVN15bxOoMdxGcxsD0Oe1W7doLVxGTwfujjn6eteV3GiXuisdS8KYVGJa50yQ\/uJd3Ux8fI\/\/jp74qlb+NdPubSQfMURtlzaT8SQt3BXqPbBweor1qOMlTeq1PLqYZSV1sfQKBSo2857nj9KoXCgKcevNfLs\/wAbh8NfFWl6F4o82TQ9fuPsOlaq\/SC+OStpM3TDqP3THqcr1r6ZM8VwnnxHKsOCK+hw+JjUXmeVWw8qbuUiWHB71SnPPIxxWhIMnaOoHbvWNd3dlDJ5MjEyEYEUY3uSenAzWs5qO5EYN6RMGVQG3Ic8\/hViEPyZB8oGd2eMVHqDz2Vq19etbaXbICzT6gyhseoTPH41+ZP7R\/8AwUs\/Zc+Bxn0m61qXxNq0QYLp+lnzV3ejbDsUfU1wPEJt2O6lg6k9Iq7P0ovfEOk2HyGZXbPCx\/N+o4r5Q+Pf7aHwf+BOky6h471qysAi5W3DiS4c46CNcmv5mv2h\/wDgr38aviRJPp\/w8EPhHS2ymLfEt26H1fBC\/wDAc1+XWr+PvFviK8u9f1K7uNQmvwY7m71BjM8gJ9XJxj2x9KzqY9bHv4bhmo\/enofuD+0h\/wAFtde1KyuIPgLpCJEWaBNV1l\/nLf344FO4j03Fa\/Eb4o\/Gn4zfHfUjr3xP16\/1UuSywPIVgjB5wsS4Qfln3rym+0oW1x5kZLK43AdlNJBdNEpgmfC5+Ur\/AFrKNdyZ3Ty2FFe7HU7j4ZeP\/FPwg8YWHj\/wlcyWt7ptwtxA8ZIYFTkg88g9x6V\/bt+y9+2Z8Pv2jf2Y5PjfqVxDZPoOnyzeKoSRm2NtHvkfB7MBlfUnHWv4UDJbyEvvyv8AdB645\/nXsPwW+K2teGINY+GeqX9xZ+H\/ABRarYarbxSMkcqBg0ZkVSN6q+CV7jPbivTwrg6kY1Nm1f0PCzCi3GUorVbH1x\/wUW\/4KDfEH9vJtM+Cvh7TxoXgmx1mTUbO0kil+1ziNGX7XdzhgA4QsUjVdqnHJPT8xfFmrnTby38NeFrV5ysS2sG9F3rEvACM8Ij\/AO+mBPU16J4t8N3vw612TwpqnlRs6\/a7zVLfYY2s+sexX3k5HXHc9+RXiuoaxFcNPHo0ZitGf9\/L5SrNOAekpVQNoJ4AGPWv6Qi8Ph8PCGE2PyenCrOpJ1SlpPhy1W8e6ZhfXitwzL\/o1seT8qAlTKD3U7QeQCea7L7ZdW2o23hLwXb3WseItcu1sNOs7UG5mmnmYRqEUZcuWOBxjOOw45CTV75JrTw94etri+1LUZ0tbCxsoy800kpChUjXliScDrkmv7Qf+CPn\/BJnTP2Q\/Da\/tS\/tJWcF98UdRtPO0ywnxNH4Xs5F4hiLZBvJFP72T+H7qnqT8xmWaRox1ep7NHD81ro2f+Cd37A2kf8ABPL4TyeMviGsF\/8AGDxvZQ\/2\/ecSDRbM4dNLtXx0UndPIP8AWSeyrX1V4\/8AGel\/D7wvL4m19w8srMtpa7grXEygsfTCKBlm64GOpp\/xF+JumN4kvfEviCY+TDMYoox9925wiZ7nt6da\/ODx94l8VfGHxi2s3rYhi2RWVsn+rgtyOEQHGeg3EjJJOfbLhTIKmY4j6xWXubvzfY5M\/wA5jhKPsqfxv8DzHx74p1v4h6\/LNPKWkllyx5AVudg7YG0ngdMcY61g6jp+n+C\/DE+veIpUt7e3jaVri4ZY0UR5MhJPQZBPXtxjPPYeN\/FHgT4Q+HLvxF4jnWOK2gErO7AE7SrAjOOgwB1P86\/DP9rL9sefxjp82t+MZpNK8OxN5ltp4k2XNz82QPkcEDoSPz61+6Y7MaeEo32SWiPzPAYGWIqXtq9yL9o345N8WriWSO4\/srwfpjPILqaVUFyY+fMEkUo28fcRkwOvU1+ZusePfFHx9v5vCPwzefQ\/Bts7Q3+vHEd3qO0n5UI2jkZ59OvpXNeHNH+J37ZetS3mpyf2T4Q07DRWkjGJLplOFDkYLEjqf\/119x6d4N8A+DtCg0K3gklitEEflQTxxRnAA+6rZx3GST2zX5RXr18fNzfw\/n\/wD9Gp0aeGgqaPHtF03wl8MdGh0XwzB5ccSErHEj73cYO52KqSWLKCcnhjzxXkHjXxczW0rWxIAdj5ZMgd3T93GW3lhlpXZvbBx617\/rt3oUNyY9E0qKHnDM8Sz8sc9WJJ+bcx+g7VH\/b+n6TpMipp+nDdmTL24VuMytgsDzyB9WzWdXATtaLHDEx5rtHm3wA0S0kttS+KWpxFv7PP2PS0LQhd6IFwrOGyzYIBIx83XPFc54\/vZPEMryyFmdQTKzRLHIQhwCyxkK6tKzHPHTird\/4k12zsDY2c0lvECMwwlfK3D945AAxnkAHGR2xXz34q8aajaQfY42jzjapMYVlGc4XHuenSuLEVvZx5UjtpQ5nzNnV\/DO5tf7WmWVS4tvnWVSd6hTztYY3c5OD3713Vjev4w8arbXGPsGnILu9387nf\/VxkKcE4xnPNfOul69F4X0OaVjnzcAqcnzD2\/HPGKrxfEq58P6b\/AMIn4eSS7vrmX7XfyQOTulfkIOvyoOv5Vrg8fGCSZhiKTk7o+s9f8eWIYgm2HIIX5lPLlyRk4xwO1cknjaOQiSJsjK\/LHLnlcuflznk9fX6V5h4R+G\/xF8ZOLq5+0RKwBKfeOCADyRx+NfTmgfBPSdGRJ9ZkjjYYR1mAdyzDAHHfH5V7NOvKd5NWPPnTUdEzi9CvNU1V0KpMWUxk74dwOwNIeRnOWI7c9AO9ex6D4bniiF1epbjCqodkkTCxqSW+UgDDMx9eB65qWfWvB\/hjMOkIrzDKpI4Cjj7zgL1A6DjkivcPgr+zD+01+1pr0dj8N\/D999iuP3b6nqEbQWqRZ6B8AszdeATTrY+nRXNOViqVCUtEfON5rAgJ8j5Y8rs5ZhtT5Y1KnkZ5Y+1LoNt4j8V36aR4U0+7v7wuBFbWcZmJxyWXbkqcnOM9fpX9Un7NH\/Bu74aht7XXPj9qtxq90cSS2sJ+z2wJ5IwPmZeBwTyK\/eH4GfsBfs5fAawitfBegafbmMD54oVDEjuXxuJ59a+MxvGtGEn7JXZ61LL9NWfxPfAv\/glX+2X8bLu3kOiDQ7SRkzdaoSJUVsZ\/dJycD1xX7b\/Bn\/g3Q+HslvBdfGXWNS1SXIaa3ik+ywE\/7qfPj2zX9Pml6DYabEsOmW0USqNoEaDp\/P8AWu80vTtzfPnHBr5jFcT4qvpflOyGDhDU\/LT4Lf8ABH39jv4QX9nrXhjwxp0d7aD91dLCrTKSMH942W57881+nPhH4XeFPC9utvo9nFEqAAbVGf5V6Ta2ChhwCK3YIAp4FeVLmqPmm7spzS+Ew00aBUA8sdP7v\/1qd\/Y8P\/PP\/wAd\/wDrV0\/HoPyo49B+VX7JGfMz\/9P+q\/xTqkEUccSHO4nJH0rk0vYnUBeSR07mr3i6wubgq8H+rRj+tctbafexIyx8bvlDn2r8lxEm5PQ+\/oQXKlc159lySFIGRzWbBpxjIiiddvUj1rTsNDnZd8zj3Pv6VX8U+I\/Afw90s6v421aw0u3xkT6hcJApxzgbyM\/hShhnLZDlVS0TKV94clul+QgEchu+axW07XrBMsolHTr2r548Q\/8ABQH9j3RZGt5vH2jOykq32YyTAEepRCK5a2\/4KOfsUamxjj+I+iIUGW89pIwMepZeKcsLOLuosqNaL0bPcfiF4D8IfFfwZf8Agvx\/pkGqadfQNb31hexiSORGHOQR+vUdRX5deHvir8QP+CYPim18J\/Ey41DxF8D9SuBb6F4quM3F94WmdgE0++xmSS0H\/LOYglRw3TNfqH4U+Lvw9+Jmmf278Mtd0jXrdek2l3KTqe+GCnI+hrM+IPw78GfGzwFqXg3xDElxpOswPp9\/bOoYxSkfK3zcBh24raE1Xi6VRWktjrwtRUZ++vce59deAPHOheNdEtdb0O5gu7S7gSe3uIGDxyxyKCrIwOCpB4PesDxz8OL19Xh8Y+HsmSEhLu36LcW\/8SN6leqHr2r+fv8AYC+K+p\/sdfGzW\/2UviX4u0b\/AIRfT72QaJb6vfLb6hp4ZiYwsUxXdbyDoFY7G+7wcD+i7RfjJ8LtVsxPb+IdFliZCQ8d7Ey4\/Bua6sHRqSXLVicWZU4Uav7mfMmYfxE+F2h+P\/hZqPhbUYw8UsMd1aOOGhuLdhLDIh7OjAYP4VY8J6x4htPET6FcQyTWa2MLPcD+G42DcoHct146V5j4w\/bK+BXgcf2TNqlldRqD5sqXdvHFGme7O4zivzL\/AGwf+CyXhHwZp9x4P\/ZYs49X1GSLbLr9wubK3Zh1ix\/rWH977ufWux0\/Z2k3Y4qFGdduKifrp8WvjT8L\/gtoL+I\/jL4jsPDdjGMiOaUCaXHOOMnJ9AM1+PHx6\/4LhfDPwfbTaV+zjoT6xJhlXUrlWgiJ\/vlpB5jfgBX81Hxv+LnxC+MWrTeL\/ilq17rV\/M24tdylo0OeiJ91F9ABXgFp4j1C7UWF0GXJCRqhOeT0981zVa0pXbeh9NgskowaU\/efbofdv7Rn\/BQP9pP4\/PLeeNfE13DZOSRo+klooFX0Yg7m+pP4V8Bv8RLPVBJFZlvPV9pjIPfuWPWtHWNJ1GHX7fwNn7JqVzMiyx3BCJEsgGwOexOeRX0\/4U\/YG+KGlata6t4\/jhTQGIlub+0lWQCMjOdymuGrVhT96T1PscJhKk\/cpwSWxzv7M\/7Mc3x28cxxeM7p7HSUG9nU+W7n+6C1fu0P2Iv2YtI8H2lnLbiTyI9m+RyCxHc8dfevFf2S\/CPgbwtqV94S+HU+n+JrlU+2R6bb3PmyxoOMsSDjmvszX\/DvxX1TSobpNItbMKxV4Zyzjb6HHf0rzvbTnd2PblhoUWqfOl3Z+XPxv\/YV8MPbz3\/wwkmEpX91ZKPNVjzyGHQV+QvijwxqHh7VZdI1WCWC6gdo5IZF2kMpweD\/AJ5r+074CfBa70v4f3WteMtMN7eajdNcxpa\/I0SDhYxuPABGa\/OX\/gof+xZZeNLCL4heBrZbDUoLVpZbWYANchc5TKg\/vFx+Nelh1Upx5pu6PBxlahiZunBWa69z+Yu5jdR8nyn+XtWS97PbyAvubnueme4+lek+INOudLuJbPUYxC8RIYSqVYFTggj1rza5AuRsjChlzgv3r2aVVSW58bjMHKnJqeh9J2Ulr8fPh7\/wr64m2a\/pKNPoM7nBuUA+a1Zsjk\/wZPBr4Z1jWLjQrhtIuopFvPONl9jKZl87OPLCgNkrkcepA5r0Cy8RXnhXUYdcEv2UW7h4pgdm0qc\/L3r97P8Agjh8Af2V\/wBrP9r9P2jviHLb3OveGNHW70\/wtMF+yXerpIMXzIwAYxL823H3sE5xX3+QZ\/KlD2M9ex8ZmuWLm9rFH33\/AMEVf+CT9n8AdDsP2uv2nNNWXx\/q8An8N6BeKHXQLOT\/AFTlckfa5UwzE8xg44Oa\/eD9or4r+FPhJ4CebxNeJHfXyMbOyX5pp29VUc7QTyTgV5l+0H+0noHwPsnuBGl\/r00eNL0kNwueks+PuoD0HfpX42eLvGni\/wCI\/im48YeP7yS61G6m53n5Y0dBiNFHCqo6Advev0HhrhOrmEvb4jSB8BnnEMcK\/Z09ZfkS61rWt+J9U\/tDWyQjS7khB4Qty2McE5YDpzXCeMviBofw58PzaveypEkEaSs0gOESNSGbI6nJB9\/SruteIraxspNQdh+7zc7iQpyoxj9Ovtiv5+P21\/2qrfxsmr2Md5LB4P0CWS21e9tpPnv7txujsbcgjO45MhydicHk1+zzjh8uw+iskfntFVsbW5patnI\/tUftg6T4svJPHXjC5x4atJGGhaYBtm1i7jYlZSp5FvEwHJwHI4OBX5Sznxx+0V4oPj\/4jsbfSUcyWenIQItpIIATOQDnPIyTWlonhTxH8avES\/E74gIbbTlCpo2lAMkUNvk+UFGMBAuSPpk17taWqarq9ppVq222gkRwEaPHyncAwcDhRuJGOpA7V+TZjmFTH1uaekb6I\/ScBgaeGp2itWfWfw9sYvBXgG3sre2MbuDJ5UccfAx8oGd3QdK47WNVZImlYOxLZO+FOGHQZ46nH61U8R63LZ2UcKyCRAnybZpAcDjgKoUemK4ma4murOKSGUGRyeFueT6Ehh6kflXt+0jCKikcbjKTux4v2klYlI\/mzhkdVOMemf7qk1neJNauFiCiORlAy53q+QCHbryPl2\/lWQ8E4l2OXIyIx5iLIMORH1XthWJrmNcmhEhDNHl8sANyH9++M4\/3R071w1q\/utnTSpao4rxHrVwYH+0rs4wd4GAX+dvyUYr5s1i5kvbx3+6qclQQQcdx6V634qu5Lku6lipLu3IbIJ9\/YD868h8O6QPFmuJpZbYjuWmZRyYwehHGM9PpXy2LquUkkepBWR2\/w+8Dy\/EK+\/tLW4rldPt2AhCkqsjgYLeuBX2v4H8A+CPB8CppGnQRuR87yIXZs+rcn61keGtHtdEsYbaEbwE8qGBEySRwAAOTkmv0Y\/Zr\/wCCeH7Rv7Tuq28ek6TPomjTbRJqV7G8crIx5MUfXOO5wK9Wg8Phoc9dpHFU55u0D44ufE2rS3MeheFoJ555sLFbWKl5JG\/gXZtzyeTivuj9nH\/gkv8Atp\/tIXMWoahpz+GtOmYMbu+K+e4k5dliBJBxwM1\/Vn+xr\/wSV+BP7OWm2+pXmnpf6tgPNfXwWadm\/wB4jj8MV+uuiaFpPh60S00q3jhRBtCxqBwK+SzPjecpOOHVkduHy+MVdn4Cfspf8EFPgH8Jjba\/8TYB4h1NArGXUsSIpH9yIHaBn1zX7k+A\/g94E+HmnxaX4V0y1tI4lCIIkC4AGOAOBXqSfMckH06+9atrCJOnrXx2Ixlau+arJs9GNKKM+Cz3nYAT9e1b0OlDAD5+la1rZqoHT61ux22VwMVnCkhSl2Mq2tI05Irat4lVeBzT0tW3DPrV2OIBttbxj2ILtvIR8p+la0WduTVCCDLbjWkBjAFdcLmErdBaKtCLjtR5f0q9RH\/\/1P6wPEEgttJMoAOXwDjoK4A6jF5ZcsqgfMzMcAACu1vbmDUbFrUMpBXbH7H1r8Yf+Crn7Us37O3wji+HPhS68rxD4qDoZIG\/fW9kvEjgdjJwqn6ntX5rLCyqVYqmfZQxChTfOec\/t4f8FdtA+DJvPhl8AXg1PxBFuivNZcK9rZsBgrGD\/rJFPf7o\/Sv5efjh+1d8Vviprj+IPiDq97rdzM5Ym9nZ1XPURpnao9AABWDqtydZFxqWrqzkuXJYnnb1r5K8V6mLzWQlqxKAlgeAOvSvsaOXwoJLr3PDnjJVNWeieI\/HF14gi8i2lkhGDmPO0ED6Vn+GvEGladI1phn8xcSnrgn2PWuSjh+0W6sDtZTyMZP41l3Gn6kC627Euo3naMHC\/erqV1uiFd9TfvNa+LPwf8Vn4nfCXW9T0rc6zSSaXcSQbT2YqpAIPcEV+1H7BX\/Bdvxh4F8d2\/hf9sRZ9W0DUoP7OuNesEAurY5BiuJYxgSiM53Nw+CfvdK\/EzStcmvrGXTm3lgNnzHGF7jHvXhPiy3uNFv82g\/dZLIOuz1XP+FcVfL6U5Xa2OuhjZxXLe5\/e7\/wUT\/4J\/fCb\/gpN8CdM+M\/wkvdMu\/EcViLrw54n01wYr1duUildOSkmMHPKP71\/F1oGrw\/Bj43X\/wd\/aUtNb017eSTRr5JLqe3l064f5FucIw3ohwwHRl5r6I\/4J1\/8FZf2hv2F\/Eo8N6E0eveCdUnWLVPDOpvm2i85gGubVufJlX7391ujDPNfqv\/AMFOP2RND\/4KGeHo\/wBpH4TTQHxWdNicNbxqkd1bouVjnCsRkDhWx9a6aGaxwq9liHeL2fY9HC5FWxsXVwz1j0P5xfjZo3i74T+OrrwF4zup7qPaLrTtQWeR4b6xl5injfcQQw5x2PBxX1F+yV+07Z3YHwd8ezGNmG3QtQnIww\/54Oe2f4TXzz4cs\/GXxG0KL9lD4xae2neLNFmmPhDXNUkaP5APm052KnerlT5WWwGOK+adT8FeLvDd5LZ67p99p93ZTlZPNjaN45Yjxg+oIzx1qsZCjWjZamWCliqE2nFruj9v\/G1mkNnJcsVBjBZmJ4IHtXzVB411ey8QWWoeFIDcXFreRSxll+TerAjORjr68Vnfs7\/tCWHj\/TB4G8cyqusWqbFllPFzGMDPP8WOor2nxh4h8LeG9MY26xRuPmG0dx6f\/qr5DEYZxk4n2eBxy0kza0fx3e2XxZvLnxPp0Gpa7d3TSz2sqLNmRxkhdpI4yAMH8q\/SfwN8B\/2w\/wBqFY\/CemGTwz4XmgUPcag23C91jij5PoMmub\/4IrfsUeBP2lvE3ib9oX4v+fc2Gh3iWOk2byMkUlw673lcjltgwAM1+q37V3i3WP2SfBWqfEXwjerZaDCjQBZFaVbV+iyDbltgJ5z0r5jMJctRXV0fseVUubC2i7Sf3HuH7Gv7HXwQ\/Ya8OXN\/PqEE2s3ig6lrF+6qzJ12Jknav5V+h3hbxp4W8QWhuNNEc9ux+WTaNj+4J6iv5+vgZ+zjrH7R3h\/Tvjb4i+JV\/wCJob8C8FoSH00552GIEZC9hiv0n8P61ceC7SLwteXpjitogis0ZihVF6Dd0AA969DA4\/o42R8TnOSczbdXml+R9GfGLxl4k8D2MPiLwbKrWKZTUNPGOV9VzjmuC+Dvxq8DfEwz6PrQc3PnHybW9iwTjnKsSd31FfKnx2\/aQ8A6FoNtpJ17R5Lm7uEt1T7XE2DIcbioJOF75r81\/H\/7XPhrwp8cPB2h+CNR067j\/wCEjj0y+voHJ8oyD7uBjqTjOMVtWxcvaWSuicDkkZ4Z82kunyP0e\/as\/ZO\/ZtttQbxVe6Nam912V7m8SULsURdWTpjdnnmv57f2gPAvwI8PyalH4bsCs1rH5qpExAXnPTPpX7tf8FKfiKPA3ww8N+Mr6R47WUT6XM8ZBIkmj8xQM8ZOD61\/IN8W\/izrviHWp72O6naAyNbtE7bT5TAqM4PINEaE5Vbx0R3UalKOD5q6UpF7xH4q8E3U66Zc2LyZA85SRjHYDPevp\/8AZi+K+i\/s9\/FHS\/H3gBrjTb+0uY54zG+cIPvBx0wR1B4NfnF4ZjkMpvLyRXcsWDSEknbxtzXpw+IVlo9uiygOZM\/KoztGeRnOW\/GvVdOomuRnl4f6vKL9pBWP6\/NN+KsHx2tG+Kf2n7beaowkubhsHyiq427V4AA4AHFZl1HPv5w3OUDMcI7cDpxxzzX8\/X7G\/wC2\/c\/Dvx5beFfEbp\/Yt\/i1UsoAjLnBO3+96cV+yPxr+MmjaXaad4S8JajGmpeJYhJDfQxfaRp1o\/3rpoV5ZgmVjQ43ORyBmv624C4yo4jL0q7UZQWvy7H8occ8KPDY+f1e8oyen\/BPjn9p34h+O\/jT4x\/4Zi\/Z\/Ia4Zlk8U+IdrG10e2I581\/u+Y2CUjzuY9cAGvwZ+Jtn4d+Lfxhf4d+D\/M\/4V38P3+xh3ZfM1S9By80rZG+W4kyzMei4HTFf0q\/tT+Nfh\/8As4\/sOeJk+DFncR6ldwQ6NaXV7blb291DVWELXNxKQTJKyszbiTg4xjpX86dvpun\/AAw8KWfhLT5WNxErT6nesxTz76TLTTZZcEKOVyT1A9a8riHNo4uV4zvFHVkuXujDWNmZXivW\/LAgtAiqGAfyV2x7VO0qrRnGGYCMcfdB7HnuPhzbxRtNrErk+YzbGaSHb8x+YhiC\/Jzj0AFeLmGO7uRdsRECd4JHl7AqcAPHlT5ceDhsfM1e2+F9QVrPy4Fl2KwVfkt3K8BSN3fAwPqO9eJgJ81W7Z7WIp8sHY6PxHcRxIscMxVjwrpdbjn8RgfMR0FctYXUs15KkW9hb2xOJUSQHrjDDHcitrxLdzxWwmCS4UbhuWNiNoJzgcYJA4\/WvP7G\/jtoLieTYGZ1B3Dy+Il7r0+8R149K9evUtM8+jC8dBbzVhZ7\/J8sbQxXgofkXYD6ZJJ\/pXnWsXUjfKrPlTjGd3+rAUAZ\/wBo\/nW1qk0xl2qXVVYKSTuH7sb2Pryx9K4bUJ3luUsbVPtF1I4ijihVjJJIxyFUAEkscduteJiay7ndSp6HmnjfUorKwfDJjHBcbSfoTx71+kf\/AATy\/wCCafxv\/avkttW8NWElhpUxR59bvYm2srdoV\/j46Hp9a+6P+Caf\/BDn4i\/tJ+K9P+Jv7R1lcaZ4bgljurbw9MCsl1tI2vcEHKp32dT3r+7b4M\/AfwF8DvDFp4X8HWNtax20CwIIY1RUVQBtUDIAr4vMc65JP2e53wpXPyT\/AGOP+CKvwK+BCQeI\/FtqNW1XajG6vh5jqwGTsU8LyO1ftN4X8B+GfCVkll4fs4II0UBdiAHiu8FuvljI\/GrtvaZwo4r5jEYurWd5yudMaaWxVgtyg45PtVtYS3bFbMdpFCMEA1dhtkdgRWah0HzoyYLKSRwAOK6i1sPLwOnerlragVqLCRzitow7mbmyBY0VQo61p2+BgY9qriEls1dhjCnmrJL0SbiTVlIxuz\/KooSMYq+BngV1QgZSbuTqMCpY8Z5qMccU+MZYVsQXaKKKAP\/V\/qa8deJ\/Bfwf8Aap8RfGUy22laJp8l9dTvwNsSliAD1JxgCv4K\/2vf2ifFH7Wfx71T4s+JWkgs5pWTSbMZxb2UZ2wxj3Awze5I7V+4H\/AAXS\/bNtg9h+yf4LvWChl1LxUYW6nhre1Yg9M\/Ow\/wB3PWv51dC01vEeopHIVggiQySMeAFJ4rycpwqjHna3PRxtdyfKeZ\/Ey+XSNAWC3+V3UhiDg7h6\/wBK+EtT1KS71YWkTD5XDnHbNfaHxqNlZwyxwS+aEB2vghc57etfCVrKra7KwIbnoe2a6MS\/eFRikj6A0RRdWbSMGxGRk55yP51etlvbkyTKwI+YBjwcYrmtPvDp9jsLAu43cjpn1Nb+j6jDDdoiHMW7krnkd8itqXvbik7Hl2rvd6XqXnwAoVcsx7Nn1rQvoF8V6ZIHjw8cW8ydFXbyDn3rpvH+jRy7r6B0yMYReRg+tebJey2Gmy2xZh55UNt4BC9M1yzbi7G8bWPKJLC6ti37zBUFeDj6V+2f\/BKr9sLxB4L8VWvwe8U3DzW1zKqWrzPuARh9w57V+IfjH7dFb\/brL7sTAyqTksv\/ANarXgXxzrHhXWbLxb4dkZZ7OVJkZThgVOe3rXnZrl8cTQdN79D6HhXPp5fjI1uj0a8j+w\/9s39gjxN41sz8a\/2f7a11S48oXs2hSYS4WVPmL2sx7+inv0Nfin8U\/wBpP4c+K7m18MfE\/Rr7RfHlm39ma1Zahb+Ws6RjCyOCB+8wOTyD1zX7r\/8ABOL9uXSfi18LIrzXb9YJoGW1uklIJjmVQMH2bqDXtH7Xn\/BNn9nT9uq1j8fa6DYeI7aAx2HibR2WOXjlfOUDEqg+vOM81+cYLNpYebo4lvTQ\/ofNckhi8PHGYVK8vxP5UvH3wd8H+N7aLWvApi0zWrXE1pcRfIGZeQjbegPrUvhiaz8cQS6f4uhez1zTlEF7Zykj5hn94vTKsOcjivt\/4ufsq+I\/2OL+70P4leF9U1\/Qr+J10bxf4d8+7khuCm1YJLZceWS43B3O3BNfBq3Vxq13HZeNohpPiK2jVrd2Zd7xSfMI5SDhlZe2cg172EzeNaTjfTo+5+cZjkTp68tn1P6Mv+CMfxd0fw98MPGHwgt2UXllq6atFAjYkkguF2llHU7WXB\/pX6weMNGtvilol7bePLe3k0qe2ks00qRd6SJICHL56s36V\/GL8LviN4q\/Zx8c2fx18Naj5N9DOlvFaI26O4D8PDKo6ow\/LrX9O\/7Lv7Y3gL9rrweNa8Hyy2t3ZyCDWtEZgs0EuOWUjkxsfukdq8HiHB1V70Nj7fhLNoTpRo1dJLqz8s\/FX7QXxZ\/4JTeLb\/4Y+F9FXUvAniCeS88K3V1MwSwmkJ822JwQQp5UZ6V+e\/xq\/bb\/AGlPiXfmz1nxJeW2iajJ59y0MjfL6rJt5IHRVGBX9UP7Rv7MfgD9ov4eXHw+8bWQnsbkhoHQgTW0ijCzRsM7WU\/n3r+UL9qL9lD4kfsbfEQeAPFk7aj4d1EsfD+vMnyTLwTHL2WRM4I74yKnJMVTqe5PdGfEtKrF+1pfCfMXiP4geCbjw\/cWGnQ30morcAwapOxVmi7\/ACKflyeea+sv+Cevhj\/hb\/7TvhLwqWSaKC\/GrX4uD8rrafOCu7kseOlfFfiTwfdwObpBA0TfM3lcA89h0JrhfD\/xL1vwV4kt9f8ACd1Npt7p8wntbq1cxyRyIeMFf1HQ9K+xjhozpvk3PhaWa1YVk6rsj+p7\/guj8SdR0H4TeBvD+nu0Zn1y4vXwMqFgg2c8dt9fy0XGoxSb3uJTJ5vJz1z15549a\/RD9rT\/AIKWWf7Xn7Mvh34ceM9BeHxpouprNPr8bqttNb+UUfan3g8hILDpkV+Vomk3+TM6YQ44\/Xnv3\/Ku\/AYXlVpnn5lmCVlTd0dp\/wAJJKJfLseAihR2AznJqzp873tybi6ZGIBOznn0Pb9MVyQ2FyIhjIIAzzuPQk+hFbuhWl9fX0VhpdvPc3c8qww28KM7O7dFUDr713T5IR5pOyPDeMqTfLHU07htRku42AZCm3y3A2kbeh+vpX9K3\/BFX4+\/Arx\/49f4OftD2dqdYvfKt9F8Q3ADOzqCEgbeSoDDhfl6\/WvxP1v9mHx58OtT879oLUNL8HWCRxTSNeXCXF3IsqK4S3t4Szu+1hwcAHgmvnw+O9N8AfERte+EF1fG1tZw+nX14vlXLImCGZFJ25IzjORxXPhM1p1brDy+7b7znxODmmnVR\/Wz\/wAFzNU8FeCPBfh74faNa2tu8PiSa\/gSMDz5BaQGJJCRtGzfNj0z9K\/lJ1G5lv7wqylmO45DGIuN2cfxKd8n\/jqelfbf7WX7VnjT9sKz8NfFfxdeI\/8AZ+j22g3UcG0mGe3T5pZg3UyDcxbgEkelfDr6jpls2zThJDIwEZJJRgCp3cHK\/JHnH+01fo+UTUMLCnF+p8hjKb9o7lW5jMGnGTDEynhlzG0mWPdSUbzJAfwXpXZ6DdLBYQxyhWc9C9vnOSQWLocHPzH6Yrn7wQvH5agxllAYqNgG4DecrlTtXCjjGSafYCWFQ048vb855ZAAAB1XK\/KoA+pr1cJW5KlzirR5lZHoXiO8tJ7WKNPKIk2q2EYD5sZ657A1yK7HtQ4LYkkMhxgjCneevfoM+lW7nUoG01p3aQeWrEt5gfBYdMemWq58LPh346+PPjez+G\/wl0+TUdSutsXyK22BXPLytjChV655NepjsXFe+2cdCk7WOb8M+FfF3xM8VW3gb4f2Mup6xeyCOG0tVJY+acszHkAAdSelf1t\/8Epv+CIUfw8u7T40ftDQw6hr\/E0FvIN9vYhjuIjBGGk\/2u3b1r7d\/wCCWn\/BJbwB+zH4Vh8Y+MoEv\/Et6iTX+oXCAuWI+5Hn7sY7Y696\/e61s4LSJbW1jVEQYVQOgr86zXOnN8lM9KlSOf8ADHhLRvCunx6fosEdvEiqAqjngV0axAydPrVtIwO1WI4sGvnuVnUkNMJIwOAO1adlGC2KSC3Z1IA7UohkibjIx7VaQG+bZXXtVu3ttnAqlbXWVw\/68V0dp5TgYxXQrdDCSsPjRlUGrO1yM4xUmzkADirG3CdK1UO5PMisisDz6VOVZRupmMkD3zUkmeAapRsMkgY52+9asb7evrWRDyTVuEtkg\/WtYMiUbmuCD0qZF2896zo3IPNWTLxitTIu+aPb8\/8A61Hmr\/k\/\/WrO3mje1AH\/1vws1TxD44+Mfj3U\/ix4+vZtQvL66e8vLmc4MkjHcT6f7oHGOK6FNTtLTRLi5gPDfKSGHvXO+JdX0zw9pS+HNJfzCP8AWSJ03dvwrz9NSkTRSi4BkfIx1\/yaafToauLerPNPibqtzfWwhy7KgzGecc9c18pabPONXmkUbh\/ESOhBr6f+IcDwwRRl1ZniKyLHnCd+T7+1fLMVxcaZqbOGUAn5885HbivNxD947KcbrU9f0r7TqEH74b2U5weP5dq6bTLsWreUigkPySSevb8K4DTdeM8IHmxqvJfAxz6cVu6Y\/mSNLI42twuff0rXDvXUVSPQ6DxDeXLI0qEf7QCgivPtY8Rbl+woIiAAfurkeua9D1BNmitLkAkMyjqSuOua+YLJLm\/1O42nOHxuJ9+lOuk5XCnKyOllxexuJI1KyKRk+\/pXis6zeF9bNgwxFL80fpt9Dn0r3iWC2jtF3Nkqfugelec+M9I\/tXTWnQkTwnfCO2B1FZw00NHqro9l+B37Q\/xI+AGsNrXw7mhlt52R9Q024VXinVTzjOdrgdxX9PP7H3\/BTfRPGegWlnPFJotwqiO5sbo7o3B7xORt\/Dj6V\/Hp4bvzJbrGCAwO36HvX1T8BP2iv+FS+L7fT\/HNutxoV9IImmPPlsT3+nrXyfEXD8a6dSCtJdT9P4E42q4WSw1aV4dE+h\/oOfDvx78NfivoYjH2W5SaMJNBc4ZWz22twfyrz74mfsK\/swfEofY\/EPg7RJo+WSRYRE6MRjKyRlWH4GvxP+FXjrxR8Hre38deA2n1fw1qXl3UMvmGSSzLD7o65jOfwr9o\/gb+1N4E+IFhb2d9JNZ3siBmikO1GJ7rng5r8nrKWHqa6WP6Ow+BjjaTq0op91+vmfmv4v8A+CDvwe8XatdHSPEviTQYZLv7RYW1tItzawPjA2+aGb8Ca+hP2TP+CPngv9jH4jxfFnwf4j8S6lfR2T2t5HNKptrqOQEtvgVfU5Hoa\/RzUfjJF4WuyNWspjaHlbrAA49RzmtaL9p\/4cwmOOS9aBnjyA0Zxx7gflXfDPqjhySldHylXhj2dZTVLY2rTxToC6VNZXiQ207gqEZSDxxnBGRX5vftXeAvAnxu8N3Hw2+JOmx6rpZkE8bZKSRso4kidSGVl7YP1r7K8afGfwT4myml3UFxNtCmSNAWXd+GT718ra3BPrl80cMmEbcE3jD\/AC9cAcc9q8TEYl86nF2PqsBlsZU3GrHfc\/lR\/bG\/Zq8W\/slapDexXMus+CNYDDS9UkUCW0k\/59rkjgOOx\/iFfl\/4E8P+J\/ij8QNN+H\/gmA3ep61qEdhZQJ3klfAJPZVByx7AEmv7Mf2n\/hTpPxj+EXiD4SeI4FFvq1o8dtK3Lw3iLmGVc9CGAzjkgmv5NP2c4dX+Amr+IPFEVwsXjNt\/hLw3HIpK6fJqTNBcalIwztaGFG2Y5BbPXFfonD+dTqYOo4fGtF2d9n\/mfifH\/D31TFU7P93LX0PCfEgn8JeJtS8MX01vcTadezWMs9q++F5IH2M0bd1JGQe9b3g3w34+8Thbvw3ouq6lEZltxNbWcssO6RgoBkVdo5PXPevW5Ph3+zX4MGl6lfTeJvFWsXVgJLnw5lbXZqKXLljdTAFUtZYQCArGQFskjFZHir9sL45XN7Y+EfhAdQ8MaXo+jXPhu20vQppZopbaV5GmJkYAycMQrkbgoHJxX0UMbiq8FDC0\/WUtF8lq9fRH55U9jSlerNei1\/4B9X+M\/wBk\/wCEv7POuI\/7R3xBsspptrqX\/CP+HU8+8vbiTLzWMcqOyxFUwPObA3nAHBrzXxB+2vqGg6EPAnwB0uDwfoVvcST219dxw3viCZ5\/lbzL903L8vygRgYHTmvn\/wAI\/s5+NdXtLfxB8Q7210azmjgvSb+5V7y5s5nIMlvyys2FYhWYZYY4yK+lvg1rvwj+CPi\/xRpWleF9J+Ic8d1G3hnxV4gV0W1gYfIz2jFVWVXwckgdumDWVPhmSj7XMKrqtd9Ir0S\/W4POFJqOHioL8X8zzT4Hfs\/\/ABv\/AGsfGF\/ZeFnQvYx\/adY1nxFcmJLWI5OXec7mY8lVHXpxmu\/\/AGl\/2XNB+AGk6Ld6F400\/wAR3d20tvq0NoAI4ZAA0UkTAkNHIpxgnKkHNaPxk\/ag0PWJ9R13VdXhj8Q3NmlkLDQYsWsRjVQpdSVjJONrn5mDL3r4FvPEupeILw3mrXc9y7ncGnYnHrjnA\/CvbwUlKP7uNkvK33dzCq0n78rt+Z634K8cXng+7kikT7Tp14BFfWj8rIinPQ55H8JFemaz9ksJoxpredaXSC5hkjOSykgtvQ8bjJhSBjpx1r56itbi7ZELKnAIdzzg\/Q17z4LXw+vh+bw5q9woe4Iltb2fO23uIwWXpyFbgN+B7V7ODzFUppO9maPh+riYynFJcvVuxNDrp06TyxjcmQwH7tjtwT8p4JZyB+FdHDq1pcxM9wTEADwRtBCdfmHHzOf0rg9E8MeJ\/EsnmaHaS3caAsrffiATOP3jY5LEkjrwOa+2v2NP+Cfnxx\/a\/wDiPD4R0e2l0\/Qba4jTVNWDh02KeY4wM5d+T6DvX108Ryxc5I+HUNXczP2aP2V\/it+2B43h+H3wytJDbfaVGpaw8e63gQHL4dcbmyeFzX94\/wDwT6\/4Jk\/Bn9kLwHZpY2Ecurywxve3swLTXE20ZZyx4GeijgV7L+xP+wx8LP2QvhlYeFfCunW8MkEK7tqKHZyOXdupYnkmvve2gad979q+SzLNZ1nboa06fUu2VsqIqqoVQMBVGAAO1bXl8cVFEWTGF4q+MsOlebCKWxqQRqB96tCJAcKtRx2cjYJ6VfghEb5b1rRRdrgaVpansOtaDWSsMEfj\/kUtvPGvFXBOmM\/yraMUZu9znriyKH5c1JZztbyfMTWwdjjP86rNboWyCKnkfQan3Nu3l347itIkFdo71gQDZxnPtWiLgqnHP1rpje2pjKOt0Ipbfz+dTzsFFUGkMbZH5VFc3DOQnFUMvxzhSKti6xgL3rNgtZZEyTj3qWSA2+HbJAq4xe4mk9DoIF3\/ADZ7cUtxuUcVRt71WXC9ahur4JWpk1rYsee44\/z\/ACo+0P7\/AOfwrGN4hOfXn\/PNJ9rT\/P8A+ugVmf\/X\/nZ8uaX54xIHdgFVzndx2\/GlvN6RsMHcflAHI3d60fD0v9oSnCo7bNkZJ+7\/AJ9a0FspZrn90Pk3Eu+eNw9Krl0uaq54R4yF1FZmKN1Xb8zAfK3P1yK+Y9cElvL9qTkN8jkjJr6a+IwkFy7HIUY2hejDpmvC4fB3ijxlNPp+gQvNJFGbpoUGX2JyWCjtXm4jc7aesbGHpkssaBTnBPA969L0iQPsD9RyBzg15Dp5uPOCSghlk2tg45HB47Yr0OymLpw5BAySOw7UqehJ3GqXQNg0bAjcDtbttPFfM12G0m9uY3LLl+x6kmvo9bu4sbFNSgaM+Wcskqbk59QcivmLxUNmpbpW3eZl2xwOTnFaT1YHX2N0jxoowWPXnOM1qJEhm2soZcEnPOM+1edeH9QjWVfM6joPWvSbZzKTLGmOOfrUIaPCdWgj0DxPLbRZMUh8xD25\/wAK6G\/t7fxDoE2nykbtm6JvSQdP8K2vH\/hu4u0TVbIZeJdzcYJXvXC6TqMi4I7N\/LvVOVtSvU\/cz\/gj\/wDtdaLZaLefAH4pZvPszsdPjncB3hI+aNC393sPTpX7galoXhqwsD4i+Hsk+paXuMxtbfC3Ngw6\/IR0HXjANfxR+CfF6fCr4k2XxEkge4sTJ5V\/DE2H2t1dCOjL1H0x3r9xPgd+1N4a1uWLVPBXiq48\/ohLlpQD0SeBiCfQ5B\/Wvyzi3IZe1damvde5\/S\/hpxxSeFjhq8rTjt6H9EXwp\/ac+Fp8JSab421eO+h3CE2ckEjT5GeAuD6cnOPeuzKfCvWrCbUNNttQ0+2mQywsEE3H8J2glhj0r8jvh78Y2svFf27xNZabfWcx2XlxppCMM9ZDb8MpyeQBX2x4F8aeDl1EHwRq6jrJ\/Z86sQw9F9Dz0r4WrQcLaH6fRxirt++z2Nta+Ak181vc6tLDMABI5geJhj+6uCcmus8LWnhPUbl5\/DzztEuVS7vAVVQfTd6nrXSeDvFfw+8RF9J8WWcdpegBFkeFAOedx45\/OvVrfwn4auC1nYSwix80MrxAKGZRyMD0rLR9Ca1WVN7s+Zf2gNH0Hwx4FfXJbm3nupUZY4YPnIdl6jp6V\/IL468Dat4Y8U6jB4v069sLprqa4j+3W7wGWORy0bx7gN6EEYdeD+Ff2kaz8PNP8deMtP8ABem+VPdXtytpbeeQiAu2MluijHWvxq\/4LDfsXXPwU18ePvD1jY2Olvf\/ANn3en\/8JB\/bF3p13t4gWFjmO3lVfNTAGCxHFfq\/hPT5MTUlbR6H4r4y41Tw9Gm5Xle5+Doh04x7hEnmY5bA7fzNVWt4I4CLUKDtzleDz9Oe9WuSihFYfKSAwI6dQegA\/l+NIVmiTdIOcBAX49weSa\/or2cNWor7j+cXNrqc1bvEXUFv9XgRqxOEBPIUY45rpIY7aQCMQ\/fyZG2HDfXOBzWBLC4k88ADIPQ+vHYjvV63feMS4bGGYYHbrk5xUxhTfuyivuJqOS2ZPd\/D3wjriFJbG2DEZJVF5J7nauP\/AB6vKtT+DulaVc\/bPswMLPyqlsDB9uma96tySAyEswBQqfmHtwvH5g1tR3aG3WO7RGUj7pwWyPRVBx+fNVVy+jKOkEZxxtSLs5HjWg+FtGZFMFjGCGKjILgg\/wC0ecivbtO0LQ9OtEfUbe3w33A8ajco6jB53YPNUYI7CxnFzboUXrIuMA9gVyeCK9Y+Dvwl+JH7T\/xQsvhj8O7eSa5uJFFxdoMx2kKN80sjKMdOgzyfasJ0aNKHNKKOn63Wm7Oo7M9Y\/Zd\/Zz+KH7WvxIh+HXw8t5I9MSWIatqEUeyC3hIHC4AHmkdBz6mv70v2J\/2Nfh7+yn8M7Hw14csoo5UjBdio8xpCMM7nuxPJNcT\/AME9\/wBhvwB+yT8J7DQdKs0+1+WJbieVQZZZmHzyO3ckn8BxX6QRQb5Mt68enHtXwOb5k8RPljoka0aVhi25kO6Tp0\/Cuk07T+hNR7IxjgDjit+2cCMCvJhBbG0tiRrVCuB1FKLVQvHNPWUZwanAGCc9jmuhxRCmya3VVUZ\/WppEyuABWVM7xkbT\/wDXpovZlOWpNrZl8r3uX4oJCcHgVO6uvGcY71ivrJTjFYN3rpBOWHuM0Nq2hcUzr3vViGcjgdCaW31WB87iD615sJ7\/AFCUKpZVzwAa3IbB4l3SMaUaj6FulHqdi2sW5bYn4YrSiud6cV52gWKUOSTXQ29\/Ei7VNbQqdzCUOx03lvKdwzTm2oQG5PfNYkeqbeAf5\/4VBdakPvZ57VatuJQO\/guEZBjpiqd9dIV29fpXmcurXSn92TVNtduIhiQ5NaxrIn2OtzvVuyjbUyT3qlf37dBnpXDHxKQMADPuKqt4iaRsMPrWqlcrkZ1v9psOP6\/\/AFqP7Tb\/ACf\/AK1cgdVjz2pP7Uj9qYezZ\/\/Q\/mw8F6m7WDzZEbS\/dK88V7Hootbbw\/PHGWMy\/LGp\/iB64r5u0bUI0ggsrRSd5Abjk19BaY8a2Mc480EjgkN94DnB\/pRh5XR0ThqeH+PIGluVOCqY2MrZIXvjtXgI8UeIfBHixtY0G5aG4EDw7kOAyMMFcV794z8+5uW3FjuYszE55+lfOviC0Ed0CpwScliMnP8A9euDEr3jqo7HKfbxdMJpIwsrM0kjqTliTk5FdLBKsYUp944A9Me9c3eIyNlWOc7c4rZt5LaZFSE7XVdrMc4BHUVjCVhNWPSUhmbTCYyu1iAF65bua+a\/iTGYdRhkUE8HdjJ59K980ScpbNFNnIHHvjvXjvxHYRxxSxYcmUj14xnFdF7yTEeb6fdyw3HmRDHA+XFe0eGJ7rUzHGinIxuA9M9T\/wDrrwWCOWOfddu2N24wg87fc9BXoVl45jt2W30dTIVO0xR\/KrD\/AGm\/woktdAPp\/VbPR\/7BMSsgOwi8uXGEjX+6p\/iY+1fE7NDDey\/YjmPzHCMeu0HivSPH3ijUY9BX+0Zw0kgAitowVjjB747n3rwk3LxJw2c5+Ye4pRg7XY6k0ehS3WnS25s7or+8UDb1HNcno9xdeFNdj1PSJxHPA25MkjeAc4JHr9c1xt1qDGQEkrjHP0q2NQgvIhBdAhgcpIOv9KbpJpxeqY6WJcJKUXZo\/Ur4Ofteabrdxb+GvF81xY3OAkFxdt5iq+OAJhhsdxnp3B61+vfwv\/aPh0y0tPDfxQshfWC7TZ63YBVuLfd\/ECuN69z1NfyWpdXCyeWrF0B+Vu457Gvpb4T\/ALVnxB+FW3SryQ6tpfQ2d02do\/2G6gjtzXxmbcJKpeVH7j9V4b8SJ07QxX3n9p3hHxd4pW3XWvDVzp3ijSnhCRT5YzIp7SqPusPevUdL+I0+n7rWRbmzRiN8LA7VPXg5PX61\/M18B\/8AgoR8MdFuI7mLXtV8NTXH7u8tipKHODuDhSpGexFfsN448QfHDRf2f9N\/aJXU\/wDiiNXaNdO1a5t1j+2+ZJs+UcZJOQDtAOK\/P8Tw\/XpzUZRtc\/W8PxvhatJy9omkfth+yfpT+LPGt54j0uw8P65baLaNNqWneIr5LSMx3Ix5ilictGAWyMY7HNfnr\/wWY0PVrr4L3niTU\/B3gWdLPULGGw8aeDL7zWEQ3BYpo929ztGCzA9PvV9tfB6L4TfCr4Nw6l8PvC0fjbWr3ydbsfGGsqfLVp0Bls7i1t5Gd4owWVcxkHrivx0\/4Kj\/ABf+Fsf7P+q3ehaHpPgbxXqmu2unXOi6M1xJBqdgqmaSfypAq2\/lyBeNoLZx0r9T4Kwaw7p0k03fU\/CuN83+u4iVe3u7I\/AmSWR7je2Il3\/d44VhwB1qe5u45IFt4n4RCkYLE8rz2H\/6687i8Twyr6YOAcAfNjtn61NbeIIppQQ5xy2NwHXjsO1ftidz8tqPVnU7JJvujqeCMnG8fTp71C9tKpbA4J3HB4B6HnH5VUGrRyR+TEcHC\/3+x46fpW7bSx3asPunocBiOfyo5eqJ5+g2zuJPK8tjuZRkJ8zD5Tj7owOlbKTMj5b5Tn7vC8HvtGT7VjPFLaMJ9o6D8uh70+wTVNUv7fRNHjkub+8kFtaW8IHmSyMcKBjJ5raFVLd6GdWHNsei\/DnwB40+M\/jvT\/hn8ObRrnUtSlEUQiQlI1\/ildj\/AAqM5\/LvX96n\/BMn\/gnT4J\/ZQ+GFncXMAutZulWe+vplHmzTEDJOeig\/dXoBXxZ\/wRg\/4JjT\/AzQP+FtfFa0jk1\/VlS4fzPnNvGRlYVPtnnHU1\/SpbWUVoFRAFwAFUdABwK+Fz3NvazdOD91HVQpWRNBYk\/KQBxgD2rZt7baeeTUcKMBuFaUKEtmvnYwXQ7HNvcryxEYIFS27gDFaEiI0eF61Vit9pLMcU3FopSutRQSGwfWp7m+WCPaOT0pGEbLvBrnL25RGZWY8ntQp2KjFMvPqDkbx+NYl7rTIuQQMdqoTSXLIfswPPdqxWsroN5t4T9O1ZTm7nRCCS1NBJb+8Jc8A8iqUkU6y5kOR3xV5tWtoEEWccVlyajGzZBBpJeZom+iN211cWwC4HB61ppr0Ug\/eEe1ee3N7GvzNx361g3GtwJkqwB9zWvtLEezPYTexTD5CBVJ52jbIavDrjxrBYdXB49alt\/izoQXZdzKp981cUmJQaPbG1ZY1wTk\/Wom1RpVyp\/WvHz468PagSLW6UnsM\/8A1qvJrsKxny5AePWrVxaX2PRhqzqST07VBcayBgEA15k\/iRd2M\/rVOXxHEx2swqoysEqXY9M\/tm137W\/OpTq+noc9T9eteWJq1q\/8Y\/Oq0t4pPDf\/AF67ISuJ0j1RtXtSxPHJ\/wA96T+1rX2\/z+NeWjUoQAN544pf7Th\/vmrJ9l5n\/9H+V\/wxcCSX7WrFSx\/c\/ga+j9DlW5sxaySzIgy+0cqXIxn2r598LWkFrAGQE+Xj7\/GG7ivW9LuPNtgoJQhssBnbj0zXNhpaWOursYvia1VbgiRGZQDtZOOlfOOt2zvqTMuBtwcN6+1fUGuXTanHst3II+Rd3HHvXzv4wlNtdiOfCT8q4xwfSssV8RvQd0cVeiESOFjV\/lAXvg+uK5zzbnT9Q81cbG+Vw3+FdjFFHgsD85HA6g1lTWUTRvcyON4OQuDz7CuVFzOssb+0mhjI+Z1GWGeqn8OteaeMIrcWzTYHySBo8jOOM5PrgV1elfZ5LsKWKRkktkd64X4lQhNHk+yFs5EecEZDcH8hWyd9iYdT558Qa4bh\/LtcrFnaSPvSd8sf5e1dt4EtPPT7Vc\/Kq+gxnFeTS2M51T7CpLEMF4r1x0u7bTU0exbYzL88ncf5+tdMjCOurOf8TeJ7XVtUa3Y74Yj5YB4zj+JT61zMiqR\/o7hkyQueo+o9a7O3+F1vcnzpruVSeWKov3vzrWh+FNvsbbdTyMCOdoHX8\/502khtNnjd5DKi+YenU1mhjj5ea+gD8IzMpj+0zgH\/AGQ1N\/4UlEjgfbH2kc5UBs\/SnFx3bJ9mzwZLox8L+lSyTrLDt5z2NfQsPwW0iPAuZ5m688AfpTm+F\/hi2UebHO3oQ54queK6lKBwXw\/8J6TPY3fjrxYT\/ZmmACO2Bw97dnlIF4J293I6L6Zr+oHSP2\/IPC\/7Anw+8VePvDdvrNneX8qeH\/CWvzjUtBtYbVxb+bbxKy+UVkUtJHLnG4kV\/OprXh3SNV0i30r7Q9tBZxFIYFGFXP3iRjlm6knk1rfDPVfG\/wAM7yS30CSz1azdN62WoRmaKMg7iyAsAhzySMZrbH06OIjTpQW3V9WLC1atKU5X3P6nvhz\/AMFy\/H7\/AACl8Qy\/D7wGukeHNTXQvEtppCT2Vw1nKoWC4svmIk5PKryMdMV+Qf7Z\/wC1NZftTata3HhY60mkWXmm3tdblWWWN3C7ysvyuVJBwrDKjArzr4HfHX9hu70e50z9ozT\/ABz4buIbmbVZZPC9wl3Y6pcNGUEb28nl+SQT8r\/N+lfK2oePbV4\/tmmLdmG4Ms1sLtw8625YiIStjlgmM89avKMmhTq+1UdjbGZlKUeS5TmguUkxJlFDgnqfzwaZb3ptpygY\/u0frms678RfbYJFDruJAyevT619kfBzwr4O+J\/7F\/xEj0zQY7zxtoeq2Oo6bq0MTPdtaOdslvHjAKlQSwA+tfS4nGwo+9OVkRleSYnH1PY4Sk5y7RTb\/A+ZIdWuEffychBjk\/1rrbTWkYBZNo5bOAcnH1NePeGtQvL69fSbt47SS2ZVu2vCIvI29d2cHI9MZruzFY6nq\/2PwlLNfQx5Ju5kEMeT1OScKvoSaqGcU1JJP\/IqXDuK5W3Czva3W\/XTyPS18QfZ4S0uCAgJO1eAfqe1f0m\/8EOP+CeDfEzxBH+0n8S9Pc24bOh290nCR958Y6t29q\/L\/wD4JXf8E9\/F\/wC2V8ZoNb16IP4Q0W7UXRj+aO8njPMasAQUU\/eNf6L\/AMGvhL4Z+EHgqz8KeHbaKCOCBYiI1CjCjAAx0FeVnGbpw5KT3OCOGcG4yWqO\/wDDehWmj2EdhYoEiiUKigdAK6cxkt0pbVURevNWSVz9K+SstkbJD4lA4NaEYDLWV5mD\/wDXqyJgq54q4AXHcRgng8VkyX4JKE8dKyLzUCpOfWsKS9lnY+V29RRKp2NYx7nVyXyqmA2T2rIKPd3BZx8oNV4BGieZdN+tQ3WvW9shEZAx0rKVup02a0R0paGCLy1xx3rHv50ZPnI\/CuMuPF8bMYwMnsBUAur\/AFE4Rdi\/rWbqJ6GkabtqWrmK3ZtwyD7VmTWpYYjJq7KUtFw5y3bFYNxrIUkDj1rGdRJGtOLZlXel3czZLkViv4eeRv30nHrml1DxGyNgMTx0FclN4juN3DVySxSR208M2jo28I6W75nkB9qz7\/4e+GbpPm69iuKwz4hmZhk1ZGrO2CSBWkMU3sN4e25Sj+H+m2Dl7R3X3zVa507U7VCLeXdt9etdAuol0+bNVTc+Y2RxXdSrNmUoJHl+rah4nsFL4ZsZ6VxE\/wAQtUtGP2tGwPY17fqDpKCjAfWuB1PSILpShVT15Irsg7kwkno0eb\/8LdWBjlmB9MVtW\/xqs3jAkkwfeuZ1bwhYO7M8anivOdV8F2x4QMPoa9LDUIy1LnFI9zPxe048+ev50f8AC3tO\/wCe4\/Ovmo+B7XPMkmfqf8KT\/hB7T\/npL+Z\/wrt+qx7mdon\/0v5X9MlffFFngnmvVtOd7W4MURO0APzzya8l0z\/Xw\/WvWLb\/AI\/W\/wCua1xYU7KuxN4hlEbgoij5A+OcZP414H4ziS41Bnl5IAYH3JFe7+JfvD\/rkv8AKvDPFn\/H8\/8AuD+YpYncKT0OQ8pWl2HOBmo9VjRVQKMdv0qwv\/Hx+dRat0SuZHRLqY00YhKrHkAnJrn\/ABPGsnh6ed+WWdSCa6O7\/wBYlc\/4l\/5Fi5\/67LV0txw2PnXRMG+n1BgpkErEEgEV6F4eka6YzT4LMNx4GMivPNE63H\/XVv616B4V+5\/wE11vY547s9Z0uFJZQrZwcfrXYWkUe4rgY4FcppH+vX6iuutP9Y31rAsdNGgjG1QM4zilS3iOQRxjOKdN\/q1qSPqfp\/SmgHfY4GZlI4DADH0rLmhiaVoCo2kH+dbq\/ff\/AH1\/lWPL\/wAfR+jVEF8Rb2Rxeq6XZtA+VPWuW+HcW7xpcWLM5jFq5A3Hg+1d1qn+pb61xXw5\/wCR\/uf+vR69DL\/4qMKhyviuKI3MkjKpLOVORxheAK9vuNLsTb2qmP8A5dhzk9lGO9eKeKv9a3\/XVv5173P\/AKm0\/wCvb\/2UV9PhPiZyT0vY5bXNB0qCzMixDLLnkng88jGK9\/8A2ev2gvHfwu+D3ijQ\/D8emzWx0a4t4o76384QvLJgzoAygTgDCyEEgdK8Y8Rf8g8f7o\/rVXwF\/wAk18S\/9eD\/APow18bxfrTpX7n9F\/RzrzpYnMZ05OL9k9U7PdHkPiHxd4i8TWi2etXUk0UU0aJGcAYkG5yxABcserMSfep9c1Wa\/hs7KBI7OCRlRobIGJeCF3dSSx7k5rlX+43\/AF8Q\/wDoArWuv9Zp3\/XUf+hCvbrRXs0vJH4Tm2Kq\/W60ud35n18z\/UC\/4I2\/Bf4e\/Cr9krwxa+DLIW4OmRzuzHe7yTZd2Zsckknmv2MSRiBk1+ZH\/BLP\/k1Pwv8A9ge2\/wDQa\/TSPoK+eqfEzzpSblqXkdttWdxxiqafdq1UQ3LIppGHSqrzyiPrU8\/aqT\/6ujqBylzPI853HueK2EYw2+6PqRyTWDN\/rj9TW43\/AB7D6VjHc6nsjl9VvJ1Awepri7+7nIGT1611Wr9F+tcZfdB9ayqdTeidN4esbec+ZKCTwc\/jXWXUjQR7IsAc1z\/hn7v5fzrc1Dp+JqYbF1DiNRuZWkbJ6nFcJqV1MpIB9q7O\/wD9Yf8AeNcJqnVvrXHU6nZQ2OCvryfzOTmueuLyfB5rXvv9ZXPXPQ\/UVwwPWhsLDdTNIMmty2nlYnJ7VzcH+sFb1r1P0rtpLUyrG2Z5MAZ7VPFNJsODj6VSPQVYi+4a9KG5w1divPNIeCe1ZF1K\/wClaM3X8Kyrvt9K7KRyx3Obv2Ldccj\/ABrlL5V8t+B0zXU33T8P8a5e+\/1b\/QV7GENJ7HFOTvP1NNy3vSv98\/U02vSMj\/\/Z","width":350,"height":200},"classes":[]},{"id":4695,"url":"https:\/\/oshot.info\/members\/jcpm2025-12-23\/","url_meta":{"origin":5131,"position":2},"title":"JCPM2025.12.23","author":"Charles Runels, MD","date":"January 5, 2026","format":false,"excerpt":"JCPM2025.12.23 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of December 23, 2025 with Charles Runels, MD. \u00a0 Here's a PDF of the transcript<-- Topics Covered The Prophecy is Between the Lines Review of PRP for Interstitial Cystitis The Reason I Spent over Two Million\u2026","rel":"","context":"In &quot;Interstitial Cystitis&quot;","block_context":{"text":"Interstitial Cystitis","link":"https:\/\/oshot.info\/members\/category\/interstitial-cystitis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2025\/07\/image5.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3114,"url":"https:\/\/oshot.info\/members\/jcpm2023-10-31-osteoarthritis-peyronies-hour-glass-deformity-p-shot-ed\/","url_meta":{"origin":5131,"position":3},"title":"JCPM2023.10.31. Osteoarthritis | Peyronies | Hour Glass Deformity | P-Shot\u00ae | ED","author":"Charles Runels, MD","date":"November 12, 2023","format":false,"excerpt":"Journal Club with Pearls, & Marketing (JCPM) 2023.10.31\u00a0 Topics Discussed Include the Following... Platelet-rich plasma (PRP) in the treatment of osteoarthritis in the knee Combination therapy of PRP and hyaluronic acid (HA) in knee osteoarthritis The use of PRP in the treatment of Peyronie's disease The effectiveness of PRP in\u2026","rel":"","context":"In &quot;p shot&quot;","block_context":{"text":"p shot","link":"https:\/\/oshot.info\/members\/category\/p-shot\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/vampirefacelift.com\/members\/wp-content\/uploads\/2021\/08\/O-Shot_Oil_bottle-300x300.jpeg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3916,"url":"https:\/\/oshot.info\/members\/jcpm2025-05-20-peyronies-disease-scleroderma-prf-vs-prp\/","url_meta":{"origin":5131,"position":4},"title":"JCPM2025.05.20 | Peyronie&#8217;s Disease | Scleroderma | PRF vs. PRP","author":"Charles Runels, MD","date":"May 29, 2025","format":false,"excerpt":"Journal Club with Pearls & Marketing 2025.05.20 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0Cellular Medicine Association JCPM2025.05.20 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of May 20, 2025, with Charles Runels, MD. \u00a0 >-> The PDF of this live journal club can\u2026","rel":"","context":"In &quot;O-Shot\u00ae&quot;","block_context":{"text":"O-Shot\u00ae","link":"https:\/\/oshot.info\/members\/category\/o-shot\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/03\/image12-300x239.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":3530,"url":"https:\/\/oshot.info\/members\/jcpm2024-10-22\/","url_meta":{"origin":5131,"position":5},"title":"JCPM2024.10.22","author":"Charles Runels, MD","date":"October 27, 2024","format":false,"excerpt":"Journal Club with Pearls & Marketing 2024.10.22 \u00a0 \u00a0Cellular Medicine Association JCPM2024.10.22 The following is an edited transcript of the\u00a0Journal Club with Pearls & Marketing\u00a0(JCPM) of October 22, 2024, with Charles Runels, MD. \u00a0 >-> The PDF of the transcript of this live journal club can be seen here <-<\u2026","rel":"","context":"In &quot;p shot&quot;","block_context":{"text":"p shot","link":"https:\/\/oshot.info\/members\/category\/p-shot\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/cellularmedicineassociation.org\/wp-content\/uploads\/2024\/07\/dr-runels.jpg?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/comments?post=5131"}],"version-history":[{"count":2,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5131\/revisions"}],"predecessor-version":[{"id":5133,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/posts\/5131\/revisions\/5133"}],"wp:attachment":[{"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/media?parent=5131"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/categories?post=5131"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/oshot.info\/members\/wp-json\/wp\/v2\/tags?post=5131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}